prescribing guide 500h - 2020 - caremark · sitagliptin/metformin ext-rel janumet xr a separate...

56
1 Prescribing Guide 500H - 2020 05/01/2020 INTRODUCTION....................................................................................................................................................................................................... 4 PREFACE ................................................................................................................................................................................................................. 4 PHARMACY AND THERAPEUTICS (P&T) COMMITTEE ...................................................................................................................................... 5 DRUG LIST PRODUCT DESCRIPTIONS ................................................................................................................................................................ 5 GENERIC SUBSTITUTION ...................................................................................................................................................................................... 5 LEGEND ................................................................................................................................................................................................................... 6 NOTICE..................................................................................................................................................................................................................... 6 ANALGESICS........................................................................................................................................................................................................... 7 NSAIDs ........................................................................................................................................................................................................... 7 NSAIDs, COMBINATIONS ............................................................................................................................................................................. 7 NSAIDs, TOPICAL ......................................................................................................................................................................................... 7 COX-2 INHIBITORS ....................................................................................................................................................................................... 7 GOUT ............................................................................................................................................................................................................. 7 OPIOID ANALGESICS ................................................................................................................................................................................... 7 NON-OPIOID ANALGESICS.......................................................................................................................................................................... 8 VISCOSUPPLEMENTS ................................................................................................................................................................................. 8 ANTI-INFECTIVES ................................................................................................................................................................................................... 8 ANTIBACTERIALS ......................................................................................................................................................................................... 8 ANTIFUNGALS .............................................................................................................................................................................................. 9 ANTIMALARIALS ........................................................................................................................................................................................... 9 ANTIRETROVIRAL AGENTS ........................................................................................................................................................................ 9 ANTITUBERCULAR AGENTS ..................................................................................................................................................................... 10 ANTIVIRALS................................................................................................................................................................................................. 10 MISCELLANEOUS ....................................................................................................................................................................................... 11 ANTINEOPLASTIC AGENTS ................................................................................................................................................................................ 11 ALKYLATING AGENTS ............................................................................................................................................................................... 11 ANTIMETABOLITES .................................................................................................................................................................................... 11 HORMONAL ANTINEOPLASTIC AGENTS ................................................................................................................................................. 12 IMMUNOMODULATORS ............................................................................................................................................................................. 12 KINASE INHIBITORS ................................................................................................................................................................................... 12 TOPOISOMERASE INHIBITORS ................................................................................................................................................................ 12 MISCELLANEOUS ....................................................................................................................................................................................... 12 CARDIOVASCULAR .............................................................................................................................................................................................. 13 ACE INHIBITORS......................................................................................................................................................................................... 13 ACE INHIBITOR/CALCIUM CHANNEL BLOCKER COMBINATIONS ........................................................................................................ 13 ACE INHIBITOR/DIURETIC COMBINATIONS ............................................................................................................................................ 13 ADRENOLYTICS, CENTRAL....................................................................................................................................................................... 13 ALDOSTERONE RECEPTOR ANTAGONISTS .......................................................................................................................................... 13 ALPHA BLOCKERS ..................................................................................................................................................................................... 14 ANGIOTENSIN II RECEPTOR ANTAGONISTS/DIURETIC COMBINATIONS ........................................................................................... 14 ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER COMBINATIONS ......................................................... 14 ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER/DIURETIC COMBINATIONS ....................................... 14 ANTIARRHYTHMICS ................................................................................................................................................................................... 14 ANTILIPEMICS............................................................................................................................................................................................. 15 BETA-BLOCKERS ....................................................................................................................................................................................... 15 BETA-BLOCKER/DIURETIC COMBINATIONS ........................................................................................................................................... 16 CALCIUM CHANNEL BLOCKERS .............................................................................................................................................................. 16 CALCIUM CHANNEL BLOCKER/ANTILIPEMIC COMBINATIONS ............................................................................................................ 16 DIGITALIS GLYCOSIDES ............................................................................................................................................................................ 16 DIRECT RENIN INHIBITORS/DIURETIC COMBINATIONS ....................................................................................................................... 16 DIURETICS .................................................................................................................................................................................................. 16 HEART FAILURE ......................................................................................................................................................................................... 17 NITRATES .................................................................................................................................................................................................... 17 PULMONARY ARTERIAL HYPERTENSION .............................................................................................................................................. 17 MISCELLANEOUS ....................................................................................................................................................................................... 17

Upload: others

Post on 25-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

1

Prescribing Guide 500H - 2020

05/01/2020

INTRODUCTION....................................................................................................................................................................................................... 4 PREFACE ................................................................................................................................................................................................................. 4 PHARMACY AND THERAPEUTICS (P&T) COMMITTEE ...................................................................................................................................... 5 DRUG LIST PRODUCT DESCRIPTIONS ................................................................................................................................................................ 5 GENERIC SUBSTITUTION ...................................................................................................................................................................................... 5 LEGEND ................................................................................................................................................................................................................... 6 NOTICE ..................................................................................................................................................................................................................... 6 ANALGESICS........................................................................................................................................................................................................... 7

NSAIDs ........................................................................................................................................................................................................... 7 NSAIDs, COMBINATIONS ............................................................................................................................................................................. 7 NSAIDs, TOPICAL ......................................................................................................................................................................................... 7 COX-2 INHIBITORS ....................................................................................................................................................................................... 7 GOUT ............................................................................................................................................................................................................. 7 OPIOID ANALGESICS ................................................................................................................................................................................... 7 NON-OPIOID ANALGESICS .......................................................................................................................................................................... 8 VISCOSUPPLEMENTS ................................................................................................................................................................................. 8

ANTI-INFECTIVES ................................................................................................................................................................................................... 8 ANTIBACTERIALS ......................................................................................................................................................................................... 8 ANTIFUNGALS .............................................................................................................................................................................................. 9 ANTIMALARIALS ........................................................................................................................................................................................... 9 ANTIRETROVIRAL AGENTS ........................................................................................................................................................................ 9 ANTITUBERCULAR AGENTS ..................................................................................................................................................................... 10 ANTIVIRALS................................................................................................................................................................................................. 10 MISCELLANEOUS ....................................................................................................................................................................................... 11

ANTINEOPLASTIC AGENTS ................................................................................................................................................................................ 11 ALKYLATING AGENTS ............................................................................................................................................................................... 11 ANTIMETABOLITES .................................................................................................................................................................................... 11 HORMONAL ANTINEOPLASTIC AGENTS ................................................................................................................................................. 12 IMMUNOMODULATORS ............................................................................................................................................................................. 12 KINASE INHIBITORS ................................................................................................................................................................................... 12 TOPOISOMERASE INHIBITORS ................................................................................................................................................................ 12 MISCELLANEOUS ....................................................................................................................................................................................... 12

CARDIOVASCULAR .............................................................................................................................................................................................. 13 ACE INHIBITORS......................................................................................................................................................................................... 13 ACE INHIBITOR/CALCIUM CHANNEL BLOCKER COMBINATIONS ........................................................................................................ 13 ACE INHIBITOR/DIURETIC COMBINATIONS ............................................................................................................................................ 13 ADRENOLYTICS, CENTRAL ....................................................................................................................................................................... 13 ALDOSTERONE RECEPTOR ANTAGONISTS .......................................................................................................................................... 13 ALPHA BLOCKERS ..................................................................................................................................................................................... 14 ANGIOTENSIN II RECEPTOR ANTAGONISTS/DIURETIC COMBINATIONS ........................................................................................... 14 ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER COMBINATIONS ......................................................... 14 ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER/DIURETIC COMBINATIONS ....................................... 14 ANTIARRHYTHMICS ................................................................................................................................................................................... 14 ANTILIPEMICS............................................................................................................................................................................................. 15 BETA-BLOCKERS ....................................................................................................................................................................................... 15 BETA-BLOCKER/DIURETIC COMBINATIONS ........................................................................................................................................... 16 CALCIUM CHANNEL BLOCKERS .............................................................................................................................................................. 16 CALCIUM CHANNEL BLOCKER/ANTILIPEMIC COMBINATIONS ............................................................................................................ 16 DIGITALIS GLYCOSIDES ............................................................................................................................................................................ 16 DIRECT RENIN INHIBITORS/DIURETIC COMBINATIONS ....................................................................................................................... 16 DIURETICS .................................................................................................................................................................................................. 16 HEART FAILURE ......................................................................................................................................................................................... 17 NITRATES .................................................................................................................................................................................................... 17 PULMONARY ARTERIAL HYPERTENSION .............................................................................................................................................. 17 MISCELLANEOUS ....................................................................................................................................................................................... 17

Page 2: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

2

CENTRAL NERVOUS SYSTEM ............................................................................................................................................................................ 18 ANTIANXIETY .............................................................................................................................................................................................. 18 ANTICONVULSANTS .................................................................................................................................................................................. 18 ANTIDEMENTIA ........................................................................................................................................................................................... 18 ANTIDEPRESSANTS .................................................................................................................................................................................. 19 ANTIPARKINSONIAN AGENTS .................................................................................................................................................................. 19 ANTIPSYCHOTICS ...................................................................................................................................................................................... 20 ATTENTION DEFICIT HYPERACTIVITY DISORDER ................................................................................................................................ 20 FIBROMYALGIA........................................................................................................................................................................................... 21 HYPNOTICS................................................................................................................................................................................................. 21 MIGRAINE .................................................................................................................................................................................................... 21 MOOD STABILIZERS .................................................................................................................................................................................. 21 MOVEMENT DISORDERS .......................................................................................................................................................................... 22 MULTIPLE SCLEROSIS AGENTS .............................................................................................................................................................. 22 MUSCULOSKELETAL THERAPY AGENTS ............................................................................................................................................... 22 MYASTHENIA GRAVIS ............................................................................................................................................................................... 22 NARCOLEPSY ............................................................................................................................................................................................. 22 POSTHERPETIC NEURALGIA (PHN) ......................................................................................................................................................... 22 PSYCHOTHERAPEUTIC-MISCELLANEOUS ............................................................................................................................................. 22

ENDOCRINE AND METABOLIC ........................................................................................................................................................................... 23 ACROMEGALY ............................................................................................................................................................................................ 23 ANDROGENS .............................................................................................................................................................................................. 23 ANTIDIABETICS .......................................................................................................................................................................................... 23 ANTIOBESITY .............................................................................................................................................................................................. 25 CALCIUM RECEPTOR ANTAGONISTS ..................................................................................................................................................... 25 CALCIUM REGULATORS ........................................................................................................................................................................... 25 CARNITINE DEFICIENCY AGENTS ........................................................................................................................................................... 25 CONTRACEPTIVES .................................................................................................................................................................................... 25 ENDOMETRIOSIS ....................................................................................................................................................................................... 26 ESTROGENS ............................................................................................................................................................................................... 26 ESTROGEN/PROGESTINS ......................................................................................................................................................................... 27 ESTROGEN/SELECTIVE ESTROGEN RECEPTOR MODULATOR COMBINATIONS ............................................................................. 27 FERTILITY REGULATORS .......................................................................................................................................................................... 27 GAUCHER DISEASE ................................................................................................................................................................................... 27 GLUCOCORTICOIDS .................................................................................................................................................................................. 27 GLUCOSE ELEVATING AGENTS ............................................................................................................................................................... 27 HEREDITARY TYROSINEMIA TYPE 1 AGENTS ....................................................................................................................................... 27 HUMAN GROWTH HORMONES ................................................................................................................................................................. 27 HYPERPARATHYROID TREATMENT, VITAMIN D ANALOGS ................................................................................................................. 28 PHENYLKETONURIA TREATMENT AGENTS ........................................................................................................................................... 28 PHOSPHATE BINDER AGENTS ................................................................................................................................................................. 28 POTASSIUM-REMOVING AGENTS............................................................................................................................................................ 28 PROGESTINS .............................................................................................................................................................................................. 28 SELECTIVE ESTROGEN RECEPTOR MODULATORS ............................................................................................................................. 28 THYROID AGENTS ..................................................................................................................................................................................... 28 VASOPRESSINS ......................................................................................................................................................................................... 28 MISCELLANEOUS ....................................................................................................................................................................................... 28

GASTROINTESTINAL ........................................................................................................................................................................................... 28 ANTIDIARRHEALS ...................................................................................................................................................................................... 28 ANTIEMETICS ............................................................................................................................................................................................. 29 ANTISPASMODICS ..................................................................................................................................................................................... 29 CHOLELITHOLYTICS .................................................................................................................................................................................. 29 H2 RECEPTOR ANTAGONISTS .................................................................................................................................................................. 29 INFLAMMATORY BOWEL DISEASE .......................................................................................................................................................... 29 IRRITABLE BOWEL SYNDROME ............................................................................................................................................................... 29 LAXATIVES .................................................................................................................................................................................................. 30 OPIOID-INDUCED CONSTIPATION ........................................................................................................................................................... 30 PANCREATIC ENZYMES ............................................................................................................................................................................ 30 PROSTAGLANDINS .................................................................................................................................................................................... 30 PROTON PUMP INHIBITORS ..................................................................................................................................................................... 30 SALIVA STIMULANTS ................................................................................................................................................................................. 30 STEROIDS, RECTAL ................................................................................................................................................................................... 30 ULCER THERAPY COMBINATIONS .......................................................................................................................................................... 30 MISCELLANEOUS ....................................................................................................................................................................................... 30

Page 3: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

3

GENITOURINARY .................................................................................................................................................................................................. 30 BENIGN PROSTATIC HYPERPLASIA ........................................................................................................................................................ 30 ERECTILE DYSFUNCTION ......................................................................................................................................................................... 30 URINARY ANTISPASMODICS .................................................................................................................................................................... 31 VAGINAL ANTI-INFECTIVES ...................................................................................................................................................................... 31 MISCELLANEOUS ....................................................................................................................................................................................... 31

HEMATOLOGIC ..................................................................................................................................................................................................... 31 ANTICOAGULANTS .................................................................................................................................................................................... 31 HEMATOPOIETIC GROWTH FACTORS .................................................................................................................................................... 31 HEMOPHILIA A AGENTS ............................................................................................................................................................................ 32 HEMOPHILIA B AGENTS ............................................................................................................................................................................ 32 IDIOPATHIC THROMBOCYTOPENIC PURPURA AGENTS ...................................................................................................................... 32 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AGENTS ........................................................................................................ 32 PLATELET AGGREGATION INHIBITORS .................................................................................................................................................. 32 PLATELET SYNTHESIS INHIBITORS ........................................................................................................................................................ 32 STEM CELL MOBILIZERS ........................................................................................................................................................................... 32 THROMBOCYTOPENIA AGENTS .............................................................................................................................................................. 32 MISCELLANEOUS ....................................................................................................................................................................................... 32

IMMUNOLOGIC AGENTS ...................................................................................................................................................................................... 32 ALLERGENIC EXTRACTS .......................................................................................................................................................................... 32 AUTOIMMUNE AGENTS ‡ ........................................................................................................................................................................... 32 DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) ................................................................................................................. 33 HEREDITARY ANGIOEDEMA ..................................................................................................................................................................... 33 IMMUNOMODULATORS ............................................................................................................................................................................. 33 IMMUNOSUPPRESSANTS ......................................................................................................................................................................... 33

NUTRITIONAL/SUPPLEMENTS ............................................................................................................................................................................ 33 ELECTROLYTES ......................................................................................................................................................................................... 33 VITAMINS AND MINERALS ........................................................................................................................................................................ 33

RESPIRATORY ...................................................................................................................................................................................................... 34 ANAPHYLAXIS TREATMENT AGENTS ..................................................................................................................................................... 34 ANTICHOLINERGICS .................................................................................................................................................................................. 34 ANTICHOLINERGIC/BETA AGONIST COMBINATIONS ............................................................................................................................ 34 ANTICHOLINERGIC/BETA AGONIST/STEROID INHALANT COMBINATIONS ........................................................................................ 34 ANTIHISTAMINES, LOW SEDATING.......................................................................................................................................................... 34 ANTIHISTAMINES, SEDATING ................................................................................................................................................................... 34 ANTITUSSIVES............................................................................................................................................................................................ 35 ANTITUSSIVE COMBINATIONS ................................................................................................................................................................. 35 BETA AGONISTS ........................................................................................................................................................................................ 35 CYSTIC FIBROSIS ...................................................................................................................................................................................... 35 LEUKOTRIENE MODULATORS .................................................................................................................................................................. 35 MAST CELL STABILIZERS ......................................................................................................................................................................... 35 NASAL ANTIHISTAMINES .......................................................................................................................................................................... 36 NASAL STEROIDS/COMBINATIONS ......................................................................................................................................................... 36 PHOSPHODIESTERASE-4 INHIBITORS .................................................................................................................................................... 36 PULMONARY ENZYME DEFICIENCY AGENTS ........................................................................................................................................ 36 PULMONARY FIBROSIS AGENTS ............................................................................................................................................................. 36 SEVERE ASTHMA AGENTS ....................................................................................................................................................................... 36 STEROID/BETA AGONIST COMBINATIONS ............................................................................................................................................. 36 STEROID INHALANTS ................................................................................................................................................................................ 36 XANTHINES ................................................................................................................................................................................................. 36 MISCELLANEOUS ....................................................................................................................................................................................... 36

TOPICAL ................................................................................................................................................................................................................ 36 DERMATOLOGY.......................................................................................................................................................................................... 36 MOUTH/THROAT/DENTAL AGENTS ......................................................................................................................................................... 39 OPHTHALMIC .............................................................................................................................................................................................. 39 OTIC ............................................................................................................................................................................................................. 41

WEBSITES ............................................................................................................................................................................................................. 42 INDEX ..................................................................................................................................................................................................................... 44

Page 4: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

4

INTRODUCTION

We are pleased to provide the 2020 Prescribing Guide as a useful reference and informational tool. The Prescribing Guide can assist practitioners in selecting clinically appropriate and cost-effective products for their patients.

The drugs represented have been reviewed by a National Pharmacy and Therapeutics (P&T) Committee and are approved for inclusion. The Prescribing Guide is reflective of current medical practice as of the date of review.

The information contained in this Prescribing Guide and its appendices is provided solely for the convenience of medical providers. We do not warrant or assure accuracy of such information nor is it intended to be comprehensive in nature. This Prescribing Guide is not intended to be a substitute for the knowledge, expertise, skill and judgment of the medical provider in his or her choice of prescription drugs. All the information in the Prescribing Guide is provided as a reference for drug therapy selection. Specific drug selection for an individual patient rests solely with the prescriber. The document is subject to state-specific regulations and rules, including, but not limited to, those regarding generic substitution, controlled substance schedules, preference for brands and mandatory generics whenever applicable.

We assume no responsibility for the actions or omissions of any medical provider based upon reliance, in whole or in part, on the information contained herein. The medical provider should consult the drug manufacturer's product literature or standard references for more detailed information.

National guidelines can be found on the National Guideline Clearinghouse site at https://www.ahrq.gov/gam/, on the websites listed under each therapeutic class and on the sites listed in the WEBSITES section of this publication.

PREFACE

The Prescribing Guide is organized by sections. Each section is divided by therapeutic drug class primarily defined by mechanism of action. Products are listed by generic name with brand name for reference only. Unless exceptions are noted, generally all applicable dosage forms and strengths of the drug cited are included in the Prescribing Guide. Generics should be considered the first line of prescribing. Individual pharmacy benefit plans may impose restrictions or not reimburse some products. In addition, over-the-counter (OTC) products, with the exception of insulin and diabetes monitoring products, are usually not included in the pharmacy benefit. Pharmacy law requires a valid prescription for the purchase of needles and syringes in certain states. OTC products are listed for informational purposes. If covered in the pharmacy benefit, OTC products require a valid prescription. Drugs represented in the Prescribing Guide may have varying cost to the plan member. Prescription benefit plan may alter coverage of certain products or vary copay amounts based on the condition being treated. Generic medications typically are available at the lowest cost, brand-name medications on the Prescribing Guide will generally cost more than generics, and brand-name medications not on the list will generally cost the most. The tiered format places drugs into tiers or levels of cost sharing by the plan member in the following manner: Tier 1: Lowest plan member copayment: All generic drugs, including those on the Prescribing Guide. Tier 2: Intermediate plan member copayment: Preferred brand-name products on the Prescribing Guide

selected for Tier 2. Tier 3: Highest plan member copayment: Brand-name products on the Prescribing Guide not selected for

Tier 2, and all non-preferred brand-name products. In most cases, there will be reasonable alternatives in Tier 1 or Tier 2 for products found in this highest tier.

Page 5: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

5

PHARMACY AND THERAPEUTICS (P&T) COMMITTEE

The services of an independent National Pharmacy and Therapeutics Committee ("P&T Committee") are utilized to approve safe and clinically effective drug therapies. The P&T Committee is an external advisory body of clinical professionals from across the United States. The P&T Committee's voting members include physicians, pharmacists, a pharmacoeconomist and a medical ethicist, all of whom have a broad background of clinical and academic expertise regarding prescription drugs. Employees with significant clinical expertise are invited to meet with the P&T Committee, but no CVS Caremark® employee may vote on issues before the P&T Committee. Voting members of the P&T Committee must disclose any financial relationship or conflicts of interest with any pharmaceutical manufacturers.

DRUG LIST PRODUCT DESCRIPTIONS

To assist in understanding which specific strengths and dosage forms are on the Prescribing Guide, examples are noted below. The general principles shown in the examples can usually be extended to other entries in the book. Any exceptions are noted. Products on the Prescribing Guide include all strengths and dosage forms of the cited brand-name product. cefixime Suprax Oral capsules, oral chewable tablets, oral suspension and all strengths of Suprax would be included in this listing. When a strength or dosage form is specified, only the specified strength and dosage form is on the Prescribing Guide. Other strengths/dosage forms of the reference product are not. acyclovir caps, tabs Zovirax The capsules and tablets of Zovirax are on the Prescribing Guide. From this entry, the cream and ointment cannot be assumed to be on the list unless there is a specific entry. Extended-release and delayed-release products require their own entry. sitagliptin/metformin Janumet The immediate-release product listing of Janumet alone would not include the extended-release product Janumet XR. sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing Guide. Dosage forms on the Prescribing Guide will be consistent with the category and use where listed. nystatin The above nystatin entry listed in the TOPICAL/DERMATOLOGY section is limited to the topical dosage forms. From this entry the oral formulations cannot be assumed to be on the list unless there is an entry for this product in the ANTI-INFECTIVES section of the Prescribing Guide.

GENERIC SUBSTITUTION

Generic substitution is a pharmacy action whereby a generic version is dispensed rather than a prescribed brand-name product. Boldface type indicates generic availability. However, not all strengths or dosage forms of the generic name in boldface type may be generically available. In addition, boldface type may indicate that the brand name cited is a generic. Examples of the latter include Levoxyl and Trivora.

One way to reduce out-of-pocket cost is by requesting a generic drug. Generic drugs are usually priced lower than their brand-name equivalents. Prescription generic drugs are:

Approved by the U.S. Food and Drug Administration for safety and effectiveness, and are manufactured under the same strict standards that apply to brand-name drugs.

Tested in humans to assure the generic is absorbed into the bloodstream in a similar rate and extent compared to the brand-name drug. Generics may be different from the brand in size, color, and inactive ingredients, but this does not alter their effectiveness or ability to be absorbed just like the brand-name drug.

Manufactured in the same strength and dosage form as the brand-name drugs.

Page 6: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

6

When a generic drug is substituted for a brand-name drug, you can expect the generic to produce the same clinical effect and safety profile as the brand-name drug. Brand-name drugs having a generic available may:

Incur higher copayment (tier 3)

Require payment of the difference in price between generic and brand, in addition to copayment

Require mandatory generic dispensing

LEGEND

OTC Over the counter

boldface Indicates generic availability; boldface may not apply to every strength or dosage form under the listed generic name

delayed-rel Delayed-release (also known as enteric-coated), refer to the reference brand listed for clarification

ext-rel Extended-release (also known as sustained-release), refer to the reference brand listed for clarification

NOTICE

The information contained in this document is proprietary. The information may not be copied in whole or in part without written permission. ©2020 CVS Caremark. All rights reserved.

This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. CVS Caremark does not operate the websites/organizations listed here, nor is it responsible for the availability or reliability of the websites' content. These listings do not imply or constitute an endorsement, sponsorship or recommendation by CVS Caremark.

When viewing the Prescribing Guide via the Internet, please be advised that the Prescribing Guide is updated periodically and changes may appear prior to their effective date to allow for client notification.

Page 7: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

7

ANALGESICS

Practice guidelines of pain management are available at: https://www.asahq.org NSAIDs

diclofenac sodium delayed-rel Tier 1 diflunisal Tier 1

etodolac Tier 1

ibuprofen Tier 1

nabumetone Tier 1 naproxen sodium tabs Tier 1

naproxen tabs Tier 1

sulindac Tier 1 meloxicam Tier 3 MOBIC

oxaprozin Tier 3 DAYPRO

NSAIDs, COMBINATIONS

diclofenac sodium delayed-rel/misoprostol Tier 1

NSAIDs, TOPICAL

* diclofenac sodium gel 1% Tier 1

diclofenac sodium soln Tier 1

* Listing does not include NDC 69499031866. Drug products are identified by unique numerical product identifiers, called National Drug Codes (NDC), which identify the manufacturer, strength, dosage form, formulation and package size. COX-2 INHIBITORS

celecoxib Tier 3 CELEBREX GOUT

colchicine Tier 1

probenecid Tier 1 febuxostat Tier 2 ULORIC

allopurinol Tier 3 ZYLOPRIM

OPIOID ANALGESICS Practice Guidelines for Cancer Pain Management (includes WHO analgesic ladder) are available at: https://www.asahq.org https://www.nccn.org Opioid guidelines in the management of chronic non-malignant pain are available at: https://www.asipp.org/ASIPP-Guidelines.html buprenorphine transdermal Tier 1

codeine/acetaminophen Tier 1

fentanyl transdermal Tier 1 fentanyl transmucosal lozenge Tier 1

hydromorphone ext-rel Tier 1

methadone Tier 1

morphine Tier 1 morphine ext-rel Tier 1

morphine supp Tier 1

oxycodone caps, tabs 5 mg Tier 1 oxycodone concentrate 20 mg/mL Tier 1

oxycodone/acetaminophen 5/325 Tier 1

tramadol ext-rel Tier 1 buprenorphine Tier 2 BELBUCA

fentanyl sublingual spray Tier 2 SUBSYS

Page 8: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

8

morphine/naltrexone ext-rel Tier 2 EMBEDA

oxycodone ext-rel Tier 2 XTAMPZA ER tapentadol Tier 2 NUCYNTA

tapentadol ext-rel Tier 2 NUCYNTA ER

hydrocodone/acetaminophen Tier 3 NORCO

hydromorphone Tier 3 DILAUDID morphine ext-rel Tier 3 KADIAN

morphine ext-rel Tier 3 MS CONTIN

oxycodone tabs 15 mg, 30 mg, soln 5 mg/5 mL Tier 3 ROXICODONE tramadol Tier 3 ULTRAM

NON-OPIOID ANALGESICS butalbital/acetaminophen/caffeine tabs Tier 3 ESGIC

butalbital/aspirin/caffeine Tier 3 FIORINAL

VISCOSUPPLEMENTS

sodium hyaluronate Tier 2 DUROLANE

sodium hyaluronate Tier 2 GEL-ONE

sodium hyaluronate Tier 2 GELSYN-3 sodium hyaluronate Tier 2 SUPARTZ FX

sodium hyaluronate Tier 2 VISCO-3

ANTI-INFECTIVES

Practice guidelines and statements developed and endorsed by the Infectious Diseases Society of America are available at: https://www.idsociety.org Hepatitis: CDC recommendations on the treatment of hepatitis are available at: https://www.cdc.gov/hepatitis/Resources/ Guidelines for the management of chronic hepatitis by the American Association for the Study of Liver Disease are available at: https://www.aasld.org HIV/AIDS: Guidelines for the treatment of HIV patients by the U.S. Department of Health and Human Services are available at: https://www.aidsinfo.nih.gov Infective Endocarditis: American Heart Association recommendations for the prevention of bacterial endocarditis are available at: https://professional.heart.org Influenza: Recommendations of the Advisory Committee on Immunization Practices are available at: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html International Travel: CDC recommendations for international travel are available at: https://wwwnc.cdc.gov/travel Respiratory Tract Infection/Antibiotic Use/Community Acquired Pneumonia/Other: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infection in adults are available at: https://www.cdc.gov/pneumonia/management-prevention-guidelines.html Sexually Transmitted Diseases: CDC Sexually Transmitted Diseases Guidelines are available at: https://www.cdc.gov/std/treatment/default.htm ANTIBACTERIALS Cephalosporins First Generation

cefadroxil Tier 1

cephalexin Tier 3 KEFLEX

Page 9: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

9

Second Generation

cefprozil Tier 1 cefuroxime axetil Tier 1

Third Generation cefdinir Tier 1

cefixime Tier 2 SUPRAX

Erythromycins/Macrolides

clarithromycin Tier 1

clarithromycin ext-rel Tier 1

erythromycin delayed-rel Tier 1 erythromycin ethylsuccinate Tier 1

erythromycin stearate Tier 1

fidaxomicin Tier 2 DIFICID azithromycin Tier 3 ZITHROMAX

Fluoroquinolones ciprofloxacin Tier 3 CIPRO

levofloxacin Tier 3 LEVAQUIN

moxifloxacin Tier 3 AVELOX

Penicillins

amoxicillin Tier 1

amoxicillin/clavulanate ext-rel Tier 1 ampicillin Tier 1

dicloxacillin Tier 1

penicillin VK Tier 1 amoxicillin/clavulanate Tier 3 AUGMENTIN

Tetracyclines doxycycline hyclate 20 mg Tier 1

minocycline Tier 1

tetracycline Tier 1

doxycycline hyclate Tier 3 VIBRAMYCIN ANTIFUNGALS

clotrimazole troches Tier 1 griseofulvin ultramicrosize Tier 1

itraconazole Tier 1

nystatin Tier 1 terbinafine tabs Tier 1

fluconazole Tier 3 DIFLUCAN

voriconazole Tier 3 VFEND

ANTIMALARIALS

chloroquine Tier 1

mefloquine Tier 1 atovaquone/proguanil Tier 3 MALARONE

ANTIRETROVIRAL AGENTS Antiretroviral Combinations

abacavir/dolutegravir/lamivudine Tier 2 TRIUMEQ

atazanavir/cobicistat Tier 2 EVOTAZ bictegravir/emtricitabine/tenofovir alafenamide Tier 2 BIKTARVY

darunavir/cobicistat Tier 2 PREZCOBIX

efavirenz/emtricitabine/tenofovir disoproxil fumarate Tier 2 ATRIPLA efavirenz/lamivudine/tenofovir disoproxil fumarate Tier 2 SYMFI

Page 10: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

10

efavirenz/lamivudine/tenofovir disoproxil fumarate Tier 2 SYMFI LO

elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide Tier 2 GENVOYA elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate Tier 2 STRIBILD

emtricitabine/rilpivirine/tenofovir alafenamide Tier 2 ODEFSEY

emtricitabine/rilpivirine/tenofovir disoproxil fumarate Tier 2 COMPLERA

emtricitabine/tenofovir alafenamide Tier 2 DESCOVY emtricitabine/tenofovir disoproxil fumarate Tier 2 TRUVADA

lamivudine/tenofovir disoproxil fumarate Tier 2 CIMDUO

lamivudine/tenofovir disoproxil fumarate Tier 2 TEMIXYS abacavir/lamivudine Tier 3 EPZICOM

lamivudine/zidovudine Tier 3 COMBIVIR

Fusion Inhibitors

enfuvirtide Tier 3 FUZEON

Integrase Inhibitors

dolutegravir Tier 2 TIVICAY

raltegravir Tier 2 ISENTRESS

Non-nucleoside Reverse Transcriptase Inhibitors

efavirenz Tier 1

nevirapine Tier 1 nevirapine ext-rel Tier 1

etravirine Tier 3 INTELENCE

rilpivirine Tier 3 EDURANT Nucleoside Reverse Transcriptase Inhibitors

stavudine Tier 1 abacavir tabs Tier 3 ZIAGEN

didanosine delayed-rel Tier 3 VIDEX EC

emtricitabine Tier 3 EMTRIVA

lamivudine Tier 3 EPIVIR zidovudine Tier 3 RETROVIR

Nucleotide Reverse Transcriptase Inhibitors tenofovir disoproxil fumarate Tier 3 VIREAD

Protease Inhibitors atazanavir Tier 1

darunavir Tier 2 PREZISTA

ritonavir Tier 2 NORVIR lopinavir/ritonavir soln Tier 3 KALETRA

lopinavir/ritonavir tabs Tier 3 KALETRA

ANTITUBERCULAR AGENTS isoniazid Tier 1

pyrazinamide Tier 1

ethambutol Tier 3 MYAMBUTOL rifampin Tier 3 RIFADIN

ANTIVIRALS Cytomegalovirus Agents

valganciclovir Tier 1

Hepatitis Agents Hepatitis B

entecavir tabs Tier 1 lamivudine Tier 1

Page 11: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

11

tenofovir alafenamide Tier 2 VEMLIDY

entecavir soln Tier 3 BARACLUDE Hepatitis C

ribavirin Tier 1 † ledipasvir/sofosbuvir Tier 2 HARVONI † sofosbuvir/velpatasvir Tier 2 EPCLUSA † sofosbuvir/velpatasvir/voxilaprevir Tier 2 VOSEVI

† HARVONI only for genotypes 1, 4, 5, and 6 EPCLUSA for genotypes 1, 2, 3, 4, 5, 6 VOSEVI for use in patients previously treated with an HCV regimen containing an NS5A inhibitor (for genotypes 1-6) or sofosbuvir without an NS5A inhibitor (for genotypes 1a or 3). Herpes Agents

famciclovir Tier 1

valacyclovir Tier 1 acyclovir caps, tabs Tier 3 ZOVIRAX

Influenza Agents

oseltamivir Tier 1 zanamivir Tier 2 RELENZA

MISCELLANEOUS dapsone Tier 1

linezolid Tier 1

nitrofurantoin macrocrystals Tier 1 sulfamethoxazole/trimethoprim Tier 1

sulfamethoxazole/trimethoprim DS Tier 1

tinidazole Tier 1 trimethoprim Tier 1

mebendazole chewable Tier 2 EMVERM

rifaximin 550 mg Tier 2 XIFAXAN

clindamycin Tier 3 CLEOCIN ivermectin Tier 3 STROMECTOL

metronidazole Tier 3 FLAGYL

nitrofurantoin ext-rel Tier 3 MACROBID nitrofurantoin susp Tier 3 FURADANTIN

vancomycin caps Tier 3 VANCOCIN

ANTINEOPLASTIC AGENTS

Clinical practice guidelines in oncology are available at: https://www.asco.org https://www.nccn.org ALKYLATING AGENTS

cyclophosphamide caps Tier 1

busulfan Tier 3 MYLERAN chlorambucil Tier 3 LEUKERAN

melphalan Tier 3 ALKERAN

temozolomide Tier 3 TEMODAR ANTIMETABOLITES

mercaptopurine Tier 1 capecitabine Tier 3 XELODA

methotrexate Tier 3 TREXALL

thioguanine Tier 3 TABLOID

Page 12: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

12

HORMONAL ANTINEOPLASTIC AGENTS Antiandrogens abiraterone Tier 1

flutamide Tier 1

abiraterone Tier 2 YONSA apalutamide Tier 2 ERLEADA

darolutamide Tier 2 NUBEQA

enzalutamide Tier 2 XTANDI

bicalutamide Tier 3 CASODEX Antiestrogens

tamoxifen Tier 1 Aromatase Inhibitors

anastrozole Tier 3 ARIMIDEX exemestane Tier 3 AROMASIN

letrozole Tier 3 FEMARA

Luteinizing Hormone-Releasing Hormone (LHRH) Agonists

leuprolide acetate Tier 1

leuprolide acetate Tier 2 ELIGARD leuprolide acetate Tier 2 LUPRON DEPOT

Progestins

megestrol acetate tabs Tier 1 IMMUNOMODULATORS

lenalidomide Tier 3 REVLIMID pomalidomide Tier 3 POMALYST

thalidomide Tier 3 THALOMID

KINASE INHIBITORS

erlotinib Tier 1

imatinib mesylate Tier 1 bosutinib Tier 2 BOSULIF

cabozantinib Tier 2 CABOMETYX

dasatinib Tier 2 SPRYCEL

everolimus Tier 2 AFINITOR gefitinib Tier 2 IRESSA

midostaurin Tier 2 RYDAPT

palbociclib Tier 2 IBRANCE ribociclib Tier 2 KISQALI

ribociclib + letrozole Tier 2 KISQALI FEMARA CO-PACK

lapatinib Tier 3 TYKERB pazopanib Tier 3 VOTRIENT

sunitinib Tier 3 SUTENT

TOPOISOMERASE INHIBITORS

topotecan caps Tier 3 HYCAMTIN

MISCELLANEOUS etoposide Tier 1

tretinoin caps Tier 1

niraparib Tier 2 ZEJULA olaparib Tier 2 LYNPARZA

rucaparib Tier 2 RUBRACA

sonidegib Tier 2 ODOMZO uridine triacetate Tier 2 VISTOGARD

Page 13: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

13

bexarotene caps Tier 3 TARGRETIN

hydroxyurea Tier 3 HYDREA mitotane Tier 3 LYSODREN

procarbazine Tier 3 MATULANE

vorinostat Tier 3 ZOLINZA

CARDIOVASCULAR

The Eighth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure is available at: https://jamanetwork.com/journals/jama/fullarticle/1791497 Guidelines for the evaluation and management of cardiovascular diseases in adults are available at: https://www.acc.org https://professional.heart.org ACE INHIBITORS Guidelines for the use of ACE inhibitors are available at: https://jamanetwork.com/journals/jama/fullarticle/1791497 https://professional.diabetes.org https://www.acc.org https://professional.heart.org

captopril Tier 1

fosinopril Tier 1 perindopril Tier 1

trandolapril Tier 1

benazepril Tier 3 LOTENSIN enalapril Tier 3 VASOTEC

lisinopril Tier 3 ZESTRIL

quinapril Tier 3 ACCUPRIL ramipril Tier 3 ALTACE

ACE INHIBITOR/CALCIUM CHANNEL BLOCKER COMBINATIONS amlodipine/benazepril Tier 3 LOTREL

trandolapril/verapamil ext-rel Tier 3 TARKA

ACE INHIBITOR/DIURETIC COMBINATIONS captopril/hydrochlorothiazide Tier 1

fosinopril/hydrochlorothiazide Tier 1

benazepril/hydrochlorothiazide Tier 3 LOTENSIN HCT enalapril/hydrochlorothiazide Tier 3 VASERETIC

lisinopril/hydrochlorothiazide Tier 3 ZESTORETIC

quinapril/hydrochlorothiazide Tier 3 ACCURETIC ADRENOLYTICS, CENTRAL

guanfacine Tier 1 clonidine Tier 3 CATAPRES

clonidine transdermal Tier 3 CATAPRES-TTS

ALDOSTERONE RECEPTOR ANTAGONISTS eplerenone Tier 3 INSPRA

spironolactone Tier 3 ALDACTONE

Page 14: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

14

ALPHA BLOCKERS Guidelines for the use of alpha blockers in various patient populations are available at: https://jamanetwork.com/journals/jama/fullarticle/1791497

terazosin Tier 1 doxazosin Tier 3 CARDURA

ANGIOTENSIN II RECEPTOR ANTAGONISTS/DIURETIC COMBINATIONS Guidelines for the use of angiotensin II receptor antagonists in various patient populations are available at: https://jamanetwork.com/journals/jama/fullarticle/1791497 https://professional.diabetes.org

candesartan Tier 1 candesartan/hydrochlorothiazide Tier 1

eprosartan Tier 1

irbesartan Tier 1

irbesartan/hydrochlorothiazide Tier 1 olmesartan Tier 1

olmesartan/hydrochlorothiazide Tier 1

valsartan Tier 1 valsartan/hydrochlorothiazide Tier 1

losartan Tier 3 COZAAR

losartan/hydrochlorothiazide Tier 3 HYZAAR

telmisartan Tier 3 MICARDIS telmisartan/hydrochlorothiazide Tier 3 MICARDIS HCT

ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER COMBINATIONS amlodipine/telmisartan Tier 1

amlodipine/valsartan Tier 1

amlodipine/olmesartan Tier 3 AZOR ANGIOTENSIN II RECEPTOR ANTAGONIST/CALCIUM CHANNEL BLOCKER/DIURETIC COMBINATIONS

amlodipine/valsartan/hydrochlorothiazide Tier 1 olmesartan/amlodipine/hydrochlorothiazide Tier 3 TRIBENZOR

ANTIARRHYTHMICS Guidelines for the use of antiarrhythmics and cardiac glycosides in various patient populations are available at: https://www.acc.org amiodarone Tier 1

flecainide Tier 1

propafenone Tier 1 sotalol Tier 1

dronedarone Tier 2 MULTAQ

disopyramide Tier 3 NORPACE

disopyramide ext-rel Tier 3 NORPACE CR dofetilide Tier 3 TIKOSYN

propafenone ext-rel Tier 3 RYTHMOL SR

Page 15: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

15

ANTILIPEMICS The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol is available at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625 Bile Acid Resins

colesevelam Tier 1

cholestyramine Tier 3 QUESTRAN/QUESTRAN LIGHT colestipol Tier 3 COLESTID

Cholesterol Absorption Inhibitors ezetimibe Tier 1

Fibrates * fenofibrate Tier 1

fenofibrate Tier 3 ANTARA

fenofibrate Tier 3 LIPOFEN fenofibric acid delayed-rel Tier 3 TRILIPIX

gemfibrozil Tier 3 LOPID

* Listing does not include fenofibrate tablet 120 mg. HMG-CoA Reductase Inhibitors/Combinations atorvastatin Tier 1

fluvastatin Tier 1

lovastatin Tier 1 rosuvastatin Tier 1

ezetimibe/simvastatin Tier 3 VYTORIN

pravastatin Tier 3 PRAVACHOL

simvastatin Tier 3 ZOCOR Niacins

niacin ext-rel Tier 3 NIASPAN Omega-3 Fatty Acids

icosapent ethyl Tier 2 VASCEPA omega-3 acid ethyl esters Tier 3 LOVAZA

PCSK9 Inhibitors evolocumab Tier 2 REPATHA

BETA-BLOCKERS Guidelines for the use of beta-blockers and beta-blocker combinations in various patient populations are available at: https://jamanetwork.com/journals/jama/fullarticle/1791497 https://www.acc.org

atenolol Tier 1

bisoprolol Tier 1 carvedilol phosphate ext-rel Tier 1

labetalol Tier 1

metoprolol succinate ext-rel Tier 1 pindolol Tier 1

propranolol Tier 1

nebivolol Tier 2 BYSTOLIC

carvedilol Tier 3 COREG metoprolol tartrate Tier 3 LOPRESSOR

nadolol Tier 3 CORGARD

propranolol ext-rel Tier 3 INDERAL LA

Page 16: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

16

BETA-BLOCKER/DIURETIC COMBINATIONS Guidelines for the use of beta-blockers and diuretic combinations in various patient populations are available at: https://jamanetwork.com/journals/jama/fullarticle/1791497 https://www.acc.org

atenolol/chlorthalidone Tier 1

bisoprolol/hydrochlorothiazide Tier 3 ZIAC

metoprolol/hydrochlorothiazide Tier 3 LOPRESSOR HCT CALCIUM CHANNEL BLOCKERS Dihydropyridines amlodipine Tier 1

felodipine ext-rel Tier 1

nifedipine ext-rel Tier 3 ADALAT CC nifedipine ext-rel Tier 3 PROCARDIA XL

Nondihydropyridines * diltiazem ext-rel Tier 1

diltiazem ext-rel Tier 3 TIAZAC

verapamil ext-rel Tier 3 CALAN SR

* Listing does not include generic CARDIZEM LA CALCIUM CHANNEL BLOCKER/ANTILIPEMIC COMBINATIONS

amlodipine/atorvastatin Tier 3 CADUET

DIGITALIS GLYCOSIDES

digoxin 0.125 mg, 0.25 mg Tier 1

digoxin ped elixir Tier 1

digoxin 0.0625 mg, 0.1875 mg Tier 3 LANOXIN DIRECT RENIN INHIBITORS/DIURETIC COMBINATIONS

aliskiren Tier 1 aliskiren/hydrochlorothiazide Tier 2 TEKTURNA HCT

DIURETICS Carbonic Anhydrase Inhibitors

acetazolamide Tier 1

acetazolamide ext-rel Tier 1 methazolamide Tier 1

Loop Diuretics bumetanide Tier 1

torsemide Tier 1

furosemide Tier 3 LASIX Potassium-sparing Diuretics

amiloride Tier 1

triamterene Tier 1 Thiazides and Thiazide-like Diuretics

chlorthalidone Tier 1 hydrochlorothiazide Tier 1

indapamide Tier 1

metolazone Tier 1

Page 17: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

17

Diuretic Combinations

amiloride/hydrochlorothiazide Tier 1 spironolactone/hydrochlorothiazide Tier 3 ALDACTAZIDE

triamterene/hydrochlorothiazide Tier 3 DYAZIDE

triamterene/hydrochlorothiazide Tier 3 MAXZIDE

HEART FAILURE

isosorbide dinitrate/hydralazine Tier 2 BIDIL

ivabradine Tier 2 CORLANOR sacubitril/valsartan Tier 2 ENTRESTO

NITRATES Oral

isosorbide dinitrate ext-rel tabs Tier 1

isosorbide mononitrate Tier 1 isosorbide mononitrate ext-rel Tier 1

isosorbide dinitrate oral Tier 3 ISORDIL

Sublingual/Translingual

nitroglycerin lingual spray Tier 3 NITROLINGUAL

nitroglycerin sublingual Tier 3 NITROSTAT Transdermal

nitroglycerin transdermal Tier 1

nitroglycerin transdermal Tier 3 NITRO-DUR PULMONARY ARTERIAL HYPERTENSION Endothelin Receptor Antagonists

ambrisentan Tier 1

bosentan Tier 1

macitentan Tier 2 OPSUMIT Phosphodiesterase Inhibitors

tadalafil Tier 1 sildenafil Tier 3 REVATIO

Prostacyclin Receptor Agonists selexipag Tier 2 UPTRAVI

Prostaglandin Vasodilators treprostinil ext-rel Tier 2 ORENITRAM

epoprostenol sodium Tier 3 FLOLAN

Soluble Guanylate Cyclase Stimulators

riociguat Tier 2 ADEMPAS

MISCELLANEOUS

hydralazine Tier 1

methyldopa Tier 1

midodrine Tier 1 ranolazine ext-rel Tier 1

Page 18: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

18

CENTRAL NERVOUS SYSTEM

Practice guidelines for psychiatric disorders are available at: https://www.psychiatry.org ANTIANXIETY Benzodiazepines alprazolam Tier 1

oxazepam Tier 1

clonazepam Tier 3 KLONOPIN diazepam Tier 3 VALIUM

lorazepam Tier 3 ATIVAN

Miscellaneous buspirone Tier 1

fluvoxamine Tier 1

clomipramine Tier 3 ANAFRANIL ANTICONVULSANTS Practice guidelines for the treatment of epilepsy are available at: https://www.aan.com

carbamazepine ext-rel Tier 1 clobazam Tier 1

lamotrigine Tier 1

lamotrigine ext-rel Tier 1 lamotrigine orally disintegrating tabs Tier 1

phenobarbital Tier 1

tiagabine Tier 1 topiramate ext-rel Tier 1

vigabatrin Tier 1

zonisamide Tier 1

lacosamide Tier 2 VIMPAT oxcarbazepine ext-rel Tier 2 OXTELLAR XR

perampanel Tier 2 FYCOMPA

topiramate ext-rel Tier 2 TROKENDI XR carbamazepine Tier 3 TEGRETOL

carbamazepine ext-rel Tier 3 CARBATROL

diazepam rectal gel Tier 3 DIASTAT

divalproex sodium delayed-rel Tier 3 DEPAKOTE divalproex sodium ext-rel Tier 3 DEPAKOTE ER

ethosuximide Tier 3 ZARONTIN

gabapentin Tier 3 NEURONTIN levetiracetam Tier 3 KEPPRA

levetiracetam ext-rel Tier 3 KEPPRA XR

oxcarbazepine Tier 3 TRILEPTAL phenytoin Tier 3 DILANTIN INFATABS

phenytoin sodium extended Tier 3 DILANTIN

primidone Tier 3 MYSOLINE

topiramate Tier 3 TOPAMAX valproic acid Tier 3 DEPAKENE

ANTIDEMENTIA Practice guidelines for the management of dementia are available at: https://www.aan.com

memantine ext-rel Tier 1

rivastigmine Tier 1

memantine/donepezil Tier 2 NAMZARIC

Page 19: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

19

donepezil Tier 3 ARICEPT

galantamine Tier 3 RAZADYNE galantamine ext-rel Tier 3 RAZADYNE ER

memantine Tier 3 NAMENDA

rivastigmine transdermal Tier 3 EXELON

ANTIDEPRESSANTS Although these agents are primarily indicated for depression, some of these are also approved for other indications, including bipolar disorder, obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder. Guidelines for the evaluation and management of bipolar and depressive disorders are available at: https://www.psychiatry.org Monoamine Oxidase Inhibitors (MAOIs) phenelzine Tier 3 NARDIL

tranylcypromine Tier 3 PARNATE

Selective Serotonin Reuptake Inhibitors (SSRIs)

escitalopram Tier 1

fluoxetine Tier 1 vilazodone Tier 2 VIIBRYD

vortioxetine Tier 2 TRINTELLIX

citalopram Tier 3 CELEXA

paroxetine HCl Tier 3 PAXIL paroxetine HCl ext-rel Tier 3 PAXIL CR

sertraline Tier 3 ZOLOFT

Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

desvenlafaxine ext-rel Tier 1

duloxetine delayed-rel Tier 1 venlafaxine Tier 1

venlafaxine ext-rel Tier 1

Tricyclic Antidepressants (TCAs)

amitriptyline Tier 1

doxepin Tier 1

desipramine Tier 3 NORPRAMIN imipramine HCl Tier 3 TOFRANIL

nortriptyline Tier 3 PAMELOR

Miscellaneous Agents

bupropion Tier 1

trazodone Tier 1 bupropion ext-rel Tier 3 WELLBUTRIN SR

bupropion ext-rel Tier 3 WELLBUTRIN XL

mirtazapine Tier 3 REMERON

ANTIPARKINSONIAN AGENTS Practice guidelines for the diagnosis and treatment of Parkinson's disease are available at: https://www.aan.com

amantadine Tier 1 benztropine Tier 1

carbidopa/levodopa orally disintegrating tabs Tier 1

pramipexole ext-rel Tier 1

rasagiline Tier 1 ropinirole Tier 1

selegiline Tier 1

Page 20: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

20

trihexyphenidyl Tier 1

rotigotine transdermal Tier 2 NEUPRO bromocriptine Tier 3 PARLODEL

carbidopa/levodopa Tier 3 SINEMET

carbidopa/levodopa ext-rel Tier 3 SINEMET CR

carbidopa/levodopa/entacapone Tier 3 STALEVO entacapone Tier 3 COMTAN

pramipexole Tier 3 MIRAPEX

ropinirole ext-rel Tier 3 REQUIP XL ANTIPSYCHOTICS Atypicals aripiprazole Tier 1

quetiapine ext-rel Tier 1

aripiprazole ext-rel inj Tier 2 ABILIFY MAINTENA aripiprazole lauroxil ext-rel inj Tier 2 ARISTADA

aripiprazole lauroxil ext-rel inj Tier 2 ARISTADA INITIO

cariprazine Tier 2 VRAYLAR

lurasidone Tier 2 LATUDA clozapine Tier 3 CLOZARIL

olanzapine Tier 3 ZYPREXA

quetiapine Tier 3 SEROQUEL risperidone Tier 3 RISPERDAL

risperidone long-acting injection Tier 3 RISPERDAL CONSTA

ziprasidone Tier 3 GEODON

Miscellaneous

chlorpromazine Tier 1

fluphenazine Tier 1 haloperidol Tier 1

perphenazine Tier 1

thiothixene Tier 1 trifluoperazine Tier 1

ATTENTION DEFICIT HYPERACTIVITY DISORDER Guidelines for the evaluation and management of attention deficit disorder are available at: https://www.aacap.org https://www.aap.org

amphetamine/dextroamphetamine mixed salts Tier 1

^ amphetamine/dextroamphetamine mixed salts ext-rel Tier 1 dextroamphetamine Tier 1

guanfacine ext-rel Tier 1

methylphenidate ext-rel Tier 1 amphetamine/dextroamphetamine mixed salts ext-rel Tier 2 MYDAYIS

lisdexamfetamine Tier 2 VYVANSE

atomoxetine Tier 3 STRATTERA

dexmethylphenidate Tier 3 FOCALIN dexmethylphenidate ext-rel Tier 3 FOCALIN XR

dextroamphetamine ext-rel Tier 3 DEXEDRINE SPANSULE

methylphenidate Tier 3 METHYLIN methylphenidate Tier 3 RITALIN

^ methylphenidate ext-rel Tier 3 CONCERTA

^ Listing does not include certain NDCs. Drug products are identified by unique numerical product identifiers, called National Drug Codes (NDC), which identify the manufacturer, strength, dosage form, formulation and package size.

Page 21: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

21

FIBROMYALGIA

pregabalin Tier 1 HYPNOTICS Practice parameters for the treatment of sleep disorders and clinical guidelines for the evaluation and management of chronic insomnia in adults are available at: https://aasm.org Benzodiazepines

temazepam Tier 3 RESTORIL

Nonbenzodiazepines

eszopiclone Tier 1

ramelteon Tier 1 zolpidem sublingual Tier 1

suvorexant Tier 2 BELSOMRA

zolpidem Tier 3 AMBIEN zolpidem ext-rel Tier 3 AMBIEN CR

Tricyclics doxepin Tier 2 SILENOR

MIGRAINE Guidelines for prevention and management of migraine headaches are available at: https://www.aan.com Ergotamine Derivatives

ergotamine/caffeine tabs Tier 1

dihydroergotamine inj Tier 3 D.H.E. 45 Monoclonal Antibodies

erenumab-aooe Tier 2 AIMOVIG fremanezumab-vfrm Tier 2 AJOVY

galcanezumab-gnlm Tier 2 EMGALITY

Selective Serotonin Agonists

naratriptan Tier 1

sumatriptan inj Tier 2 ZEMBRACE SYMTOUCH

sumatriptan nasal powder Tier 2 ONZETRA XSAIL zolmitriptan nasal spray Tier 2 ZOMIG

eletriptan Tier 3 RELPAX

rizatriptan Tier 3 MAXALT sumatriptan Tier 3 IMITREX

sumatriptan inj Tier 3 IMITREX

sumatriptan nasal spray Tier 3 IMITREX zolmitriptan Tier 3 ZOMIG

Selective Serotonin Agonist/Nonsteroidal Anti-inflammatory Drug (NSAID) Combinations

sumatriptan/naproxen sodium Tier 2 TREXIMET MOOD STABILIZERS

lithium carbonate Tier 1 lithium carbonate ext-rel tabs 450 mg Tier 1

lithium carbonate ext-rel tabs 300 mg Tier 3 LITHOBID

Page 22: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

22

MOVEMENT DISORDERS

tetrabenazine Tier 1 deutetrabenazine Tier 2 AUSTEDO

valbenazine Tier 2 INGREZZA

MULTIPLE SCLEROSIS AGENTS Practice guidelines for multiple sclerosis are available at: https://www.aan.com

dimethyl fumarate delayed-rel Tier 2 TECFIDERA

fingolimod Tier 2 GILENYA glatiramer Tier 2 COPAXONE

interferon beta-1a Tier 2 REBIF

interferon beta-1b Tier 2 BETASERON

natalizumab Tier 2 TYSABRI siponimod Tier 2 MAYZENT

teriflunomide Tier 2 AUBAGIO

MUSCULOSKELETAL THERAPY AGENTS

baclofen Tier 1

carisoprodol Tier 1 chlorzoxazone Tier 1

* cyclobenzaprine Tier 1

orphenadrine/aspirin/caffeine Tier 1

dantrolene Tier 3 DANTRIUM metaxalone Tier 3 SKELAXIN

methocarbamol Tier 3 ROBAXIN

tizanidine tabs Tier 3 ZANAFLEX * Listing does not include cyclobenzaprine tablet 7.5 mg. MYASTHENIA GRAVIS

pyridostigmine Tier 1

pyridostigmine ext-rel Tier 1 NARCOLEPSY

armodafinil Tier 1 solriamfetol Tier 2 SUNOSI

POSTHERPETIC NEURALGIA (PHN) gabapentin ext-rel Tier 2 GRALISE

PSYCHOTHERAPEUTIC-MISCELLANEOUS Alcohol Deterrents

acamprosate calcium Tier 1

disulfiram Tier 3 ANTABUSE Opioid Antagonists

naloxone inj Tier 1 naltrexone Tier 1

naloxone nasal spray Tier 2 NARCAN

Partial Opioid Agonist/Opioid Antagonist Combinations

buprenorphine/naloxone sublingual Tier 1

buprenorphine/naloxone sublingual tabs Tier 2 ZUBSOLV

Pseudobulbar Affect Agents

dextromethorphan/quinidine Tier 2 NUEDEXTA

Page 23: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

23

Smoking Deterrents Treating Tobacco Use and Dependence: 2008 Update-Clinical Practice Guideline is available at: https://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/index.html

bupropion ext-rel Tier 1 varenicline Tier 3 CHANTIX

Vasomotor Symptom Agents paroxetine mesylate Tier 1

ENDOCRINE AND METABOLIC

ACROMEGALY

lanreotide acetate Tier 2 SOMATULINE DEPOT pegvisomant Tier 2 SOMAVERT

ANDROGENS Clinical practice guidelines for the treatment of hypogonadism are available at: https://www.aace.com

testosterone cypionate Tier 1

testosterone enanthate Tier 1

testosterone gel Tier 1 testosterone soln Tier 1

testosterone transdermal Tier 2 ANDRODERM

ANTIDIABETICS Guidelines of treatment and management of diabetes are available at: https://professional.diabetes.org Alpha-glucosidase Inhibitors acarbose Tier 3 PRECOSE

Amylin Analogs pramlintide Tier 2 SYMLINPEN

Biguanides

metformin Tier 3 GLUCOPHAGE metformin ext-rel Tier 3 GLUCOPHAGE XR

Biguanide/Sulfonylurea Combinations glipizide/metformin Tier 1

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sitagliptin phosphate Tier 2 JANUVIA

Dipeptidyl Peptidase-4 (DPP-4) Inhibitor/Biguanide Combinations sitagliptin/metformin Tier 2 JANUMET

sitagliptin/metformin ext-rel Tier 2 JANUMET XR

Incretin Mimetic Agents

dulaglutide Tier 2 TRULICITY

liraglutide Tier 2 VICTOZA semaglutide Tier 2 OZEMPIC

Incretin Mimetic Agent/Insulin Combinations

liraglutide/insulin degludec Tier 2 XULTOPHY lixisenatide/insulin glargine Tier 2 SOLIQUA

Page 24: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

24

Insulins

insulin aspart Tier 2 FIASP insulin aspart Tier 2 NOVOLOG

insulin aspart protamine 70%/insulin aspart 30% Tier 2 NOVOLOG MIX 70/30

insulin degludec Tier 2 TRESIBA

insulin detemir Tier 2 LEVEMIR insulin glargine Tier 2 BASAGLAR

insulin human Tier 2 HUMULIN R U-500

OTC insulin human Tier 2 NOVOLIN R OTC insulin isophane human Tier 2 NOVOLIN N

OTC insulin isophane human 70%/regular 30% Tier 2 NOVOLIN 70/30

Insulin Sensitizers

pioglitazone Tier 1

Insulin Sensitizer/Biguanide Combinations

pioglitazone/metformin Tier 3 ACTOPLUS MET

Insulin Sensitizer/Sulfonylurea Combinations

pioglitazone/glimepiride Tier 3 DUETACT

Meglitinides

nateglinide Tier 1

repaglinide Tier 3 PRANDIN

Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors

dapagliflozin Tier 2 FARXIGA

empagliflozin Tier 2 JARDIANCE Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor/Biguanide Combinations

dapagliflozin/metformin ext-rel Tier 2 XIGDUO XR empagliflozin/metformin Tier 2 SYNJARDY

empagliflozin/metformin ext-rel Tier 2 SYNJARDY XR

Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor/Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Combinations

empagliflozin/linagliptin Tier 2 GLYXAMBI

Sulfonylureas

glimepiride Tier 3 AMARYL

glipizide Tier 3 GLUCOTROL

glipizide ext-rel Tier 3 GLUCOTROL XL Supplies

blood glucose continuous monitoring receivers, sensors, transmitters

Tier 2 DEXCOM CONTINUOUS GLUCOSE MONITORING SYSTEM

blood glucose monitoring kits, test strips Tier 2 ACCU-CHEK AVIVA PLUS kits and test strips

blood glucose monitoring kits, test strips Tier 2 ACCU-CHEK COMPACT PLUS kits and test strips

blood glucose monitoring kits, test strips Tier 2 ACCU-CHEK GUIDE kits and test strips

blood glucose monitoring kits, test strips Tier 2 ACCU-CHEK SMARTVIEW kits and test strips

insulin infusion disposable pump Tier 2 OMNIPOD INSULIN INFUSION PUMP

insulin infusion disposable pump Tier 2 V-GO INSULIN INFUSION PUMP OTC insulin syringes, needles Tier 2 BD ULTRAFINE

insulin syringes and needles

Page 25: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

25

ANTIOBESITY Guidelines of treatment and management of obesity are available at: https://www.aace.com https://www.nhlbi.nih.gov/health-topics/managing-overweight-obesity-in-adults

liraglutide Tier 2 SAXENDA

CALCIUM RECEPTOR ANTAGONISTS cinacalcet Tier 2 SENSIPAR

CALCIUM REGULATORS Guidelines of treatment and management of osteoporosis are available at: https://www.aace.com https://www.nof.org Bisphosphonates alendronate Tier 3 FOSAMAX

ibandronate Tier 3 BONIVA

risedronate Tier 3 ACTONEL risedronate delayed-rel Tier 3 ATELVIA

Calcitonins

calcitonin-salmon spray Tier 1 Parathyroid Hormones

abaloparatide Tier 2 TYMLOS teriparatide Tier 2 FORTEO

Miscellaneous denosumab Tier 2 PROLIA

CARNITINE DEFICIENCY AGENTS levocarnitine Tier 1

CONTRACEPTIVES EE = ethinyl estradiol ME = mestranol Monophasic 20 mcg Estrogen drospirenone/EE 3/20 Tier 1

drospirenone/EE/levomefolate 3/20 and levomefolate Tier 1

levonorgestrel/EE 0.1/20 - Lessina Tier 1

norethindrone acetate/EE 1/20 and iron chewable Tier 1 norethindrone acetate/EE 1/20 Tier 3 LOESTRIN 1/20

norethindrone acetate/EE 1/20 and iron Tier 3 LOESTRIN FE 1/20

30 mcg Estrogen

desogestrel/EE 0.15/30 Tier 1

drospirenone/EE/levomefolate 3/30 and levomefolate Tier 1 levonorgestrel/EE 0.15/30 - Levora Tier 1

norgestrel/EE 0.3/30 - Low-Ogestrel Tier 1

drospirenone/EE 3/30 Tier 3 YASMIN

norethindrone acetate/EE 1.5/30 Tier 3 LOESTRIN 1.5/30 norethindrone acetate/EE 1.5/30 and iron Tier 3 LOESTRIN FE 1.5/30

Page 26: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

26

35 mcg Estrogen

ethynodiol diacetate/EE 1/35 - Zovia 1/35 Tier 1 norethindrone/EE 0.5/35 Tier 1

norethindrone/EE 1/35 Tier 1

norgestimate/EE 0.25/35 Tier 1

norethindrone/EE 1/35 Tier 3 ORTHO-NOVUM 1/35 Biphasic

desogestrel/EE Tier 3 MIRCETTE Triphasic

desogestrel/EE Tier 1 levonorgestrel/EE - Trivora Tier 1

norgestimate/EE Tier 1

norethindrone/EE Tier 3 ORTHO-NOVUM 7/7/7 Extended Cycle

levonorgestrel/EE 0.15/30 Tier 1 levonorgestrel/EE 0.1/20 and EE 10 Tier 3 LOSEASONIQUE

levonorgestrel/EE 0.15/30 and EE 10 Tier 3 SEASONIQUE

Progestin Only

norethindrone Tier 1

norethindrone Tier 3 ORTHO MICRONOR

Injectable

medroxyprogesterone acetate 150 mg/mL Tier 3 DEPO-PROVERA

Progestin Intrauterine Devices

levonorgestrel releasing IUD Tier 2 KYLEENA

levonorgestrel releasing IUD Tier 2 MIRENA levonorgestrel releasing IUD Tier 2 SKYLA

Transdermal norelgestromin/EE Tier 1

Vaginal etonogestrel/EE ring Tier 2 NUVARING

ENDOMETRIOSIS danazol Tier 1

elagolix Tier 2 ORILISSA

ESTROGENS Guidelines of treatment and management of hormone therapy and menopause are available at: https://www.menopause.org https://www.aace.com/files/menopause.pdf Oral estrogens, conjugated Tier 2 PREMARIN

estradiol Tier 3 ESTRACE

Transdermal

estradiol Tier 1

estradiol Tier 2 DIVIGEL estradiol Tier 2 EVAMIST

estradiol Tier 3 CLIMARA

Page 27: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

27

Vaginal

estradiol vaginal crm Tier 1 estradiol vaginal ring Tier 2 ESTRING

estrogens, conjugated crm Tier 2 PREMARIN

estradiol vaginal tabs Tier 3 VAGIFEM

ESTROGEN/PROGESTINS Oral EE/norethindrone acetate - Jinteli Tier 1

estradiol/norethindrone Tier 1

estrogens, conjugated/medroxyprogesterone Tier 2 PREMPHASE

estrogens, conjugated/medroxyprogesterone Tier 2 PREMPRO Transdermal

estradiol/levonorgestrel Tier 2 CLIMARA PRO estradiol/norethindrone acetate Tier 2 COMBIPATCH

ESTROGEN/SELECTIVE ESTROGEN RECEPTOR MODULATOR COMBINATIONS conjugated estrogens/bazedoxifene Tier 2 DUAVEE

FERTILITY REGULATORS GNRH/LHRH Antagonists

ganirelix acetate Tier 1

cetrorelix Tier 2 CETROTIDE Ovulation Stimulants, Gonadotropins

choriogonadotropin alfa Tier 2 OVIDREL follitropin alfa Tier 2 GONAL-F

Ovulation Stimulants, Synthetic clomiphene Tier 1

GAUCHER DISEASE

eliglustat Tier 2 CERDELGA imiglucerase Tier 2 CEREZYME

GLUCOCORTICOIDS dexamethasone Tier 1

fludrocortisone Tier 1

prednisolone Tier 1 prednisone Tier 1

hydrocortisone Tier 3 CORTEF

methylprednisolone Tier 3 MEDROL GLUCOSE ELEVATING AGENTS

glucagon, human recombinant Tier 2 GLUCAGEN HYPOKIT

glucagon, human recombinant Tier 2 GLUCAGON EMERGENCY KIT HEREDITARY TYROSINEMIA TYPE 1 AGENTS

nitisinone Tier 2 ORFADIN HUMAN GROWTH HORMONES Guidelines for use of growth hormone are available at: https://www.aace.com/publications/guidelines somatropin Tier 2 GENOTROPIN

somatropin Tier 2 HUMATROPE

Page 28: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

28

HYPERPARATHYROID TREATMENT, VITAMIN D ANALOGS

calcitriol (1,25-D3) Tier 3 ROCALTROL doxercalciferol Tier 3 HECTOROL

paricalcitol Tier 3 ZEMPLAR

PHENYLKETONURIA TREATMENT AGENTS

sapropterin Tier 3 KUVAN

PHOSPHATE BINDER AGENTS

calcium acetate Tier 1

sevelamer carbonate Tier 1

calcium acetate Tier 2 PHOSLYRA sucroferric oxyhydroxide Tier 2 VELPHORO

POTASSIUM-REMOVING AGENTS patiromer sorbitex Tier 2 VELTASSA

sodium zirconium cyclosilicate Tier 2 LOKELMA

PROGESTINS Oral

medroxyprogesterone acetate Tier 3 PROVERA megestrol acetate susp Tier 3 MEGACE ES

norethindrone acetate Tier 3 AYGESTIN

progesterone, micronized Tier 3 PROMETRIUM

Vaginal

progesterone gel Tier 2 CRINONE

progesterone vaginal inserts Tier 2 ENDOMETRIN SELECTIVE ESTROGEN RECEPTOR MODULATORS

ospemifene Tier 2 OSPHENA raloxifene Tier 3 EVISTA

THYROID AGENTS Antithyroid Agents

propylthiouracil Tier 1

methimazole Tier 3 TAPAZOLE Thyroid Supplements

levothyroxine Tier 1 levothyroxine - Levoxyl Tier 1

levothyroxine Tier 2 SYNTHROID

liothyronine Tier 3 CYTOMEL VASOPRESSINS

desmopressin spray, tabs Tier 3 DDAVP

MISCELLANEOUS

cabergoline Tier 1

GASTROINTESTINAL

Guidelines for the treatment and management of various gastrointestinal diseases/conditions are available at: https://gi.org https://www.gastro.org ANTIDIARRHEALS

loperamide Tier 1 diphenoxylate/atropine Tier 3 LOMOTIL

Page 29: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

29

ANTIEMETICS

doxylamine/pyridoxine delayed-rel Tier 1 granisetron Tier 1

meclizine Tier 1

prochlorperazine Tier 1

promethazine Tier 1 scopolamine transdermal Tier 1

granisetron transdermal Tier 2 SANCUSO

rolapitant Tier 2 VARUBI dronabinol Tier 3 MARINOL

metoclopramide Tier 3 REGLAN

ondansetron Tier 3 ZOFRAN trimethobenzamide Tier 3 TIGAN

ANTISPASMODICS hyoscyamine sulfate ext-rel caps Tier 1

hyoscyamine sulfate orally disintegrating tabs Tier 1

dicyclomine Tier 3 BENTYL

hyoscyamine sulfate Tier 3 LEVSIN hyoscyamine sulfate ext-rel Tier 3 LEVBID

CHOLELITHOLYTICS ursodiol Tier 3 ACTIGALL

ursodiol Tier 3 URSO

H2 RECEPTOR ANTAGONISTS

cimetidine Tier 1

ranitidine Tier 1 famotidine Tier 3 PEPCID

INFLAMMATORY BOWEL DISEASE Oral Agents

balsalazide Tier 1

budesonide delayed-rel caps Tier 1

budesonide ext-rel Tier 1 mesalamine delayed-rel caps Tier 1

mesalamine delayed-rel tabs Tier 1

mesalamine ext-rel caps Tier 2 APRISO mesalamine ext-rel caps Tier 2 PENTASA

sulfasalazine Tier 3 AZULFIDINE

sulfasalazine delayed-rel Tier 3 AZULFIDINE EN-TABS Rectal Agents

hydrocortisone enema Tier 1

mesalamine supp Tier 1 hydrocortisone acetate foam Tier 2 CORTIFOAM

mesalamine susp Tier 3 ROWASA

IRRITABLE BOWEL SYNDROME Irritable Bowel Syndrome with Constipation

linaclotide Tier 2 LINZESS lubiprostone Tier 2 AMITIZA

Irritable Bowel Syndrome with Diarrhea alosetron Tier 1

eluxadoline Tier 2 VIBERZI

Page 30: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

30

LAXATIVES

lactulose soln Tier 1 sodium sulfate/potassium sulfate/magnesium sulfate Tier 2 SUPREP

peg 3350/electrolytes Tier 3 GOLYTELY

peg 3350/electrolytes Tier 3 NULYTELY

OPIOID-INDUCED CONSTIPATION

naldemedine Tier 2 SYMPROIC

naloxegol Tier 2 MOVANTIK PANCREATIC ENZYMES

pancrelipase Tier 2 VIOKACE pancrelipase delayed-rel Tier 2 CREON

pancrelipase delayed-rel Tier 2 ZENPEP

PROSTAGLANDINS

misoprostol Tier 3 CYTOTEC

PROTON PUMP INHIBITORS

esomeprazole delayed-rel Tier 1

lansoprazole delayed-rel Tier 1 pantoprazole delayed-rel Tier 1

dexlansoprazole delayed-rel Tier 2 DEXILANT

omeprazole delayed-rel Tier 3 PRILOSEC

SALIVA STIMULANTS

cevimeline Tier 3 EVOXAC

pilocarpine tabs Tier 3 SALAGEN STEROIDS, RECTAL

hydrocortisone acetate/pramoxine foam Tier 2 PROCTOFOAM-HC hydrocortisone crm Tier 3 ANUSOL-HC

ULCER THERAPY COMBINATIONS lansoprazole + amoxicillin + clarithromycin Tier 1

bismuth/metronidazole/tetracycline Tier 2 PYLERA

MISCELLANEOUS

sucralfate Tier 1

GENITOURINARY

BENIGN PROSTATIC HYPERPLASIA Guidelines for the management of BPH are available at: https://www.auanet.org/guidelines alfuzosin ext-rel Tier 1

dutasteride/tamsulosin Tier 1

silodosin Tier 1 dutasteride Tier 3 AVODART

finasteride Tier 3 PROSCAR

tamsulosin Tier 3 FLOMAX ERECTILE DYSFUNCTION Guidelines for the management of erectile dysfunction are available at: https://www.auanet.org/guidelines Alprostadil Agents alprostadil supp Tier 2 MUSE

Page 31: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

31

Phosphodiesterase Inhibitors

sildenafil Tier 1 tadalafil Tier 1

URINARY ANTISPASMODICS darifenacin ext-rel Tier 1

oxybutynin Tier 1

solifenacin Tier 1

tolterodine ext-rel Tier 1 trospium Tier 1

trospium ext-rel Tier 1

fesoterodine ext-rel Tier 2 TOVIAZ mirabegron ext-rel Tier 2 MYRBETRIQ

oxybutynin ext-rel Tier 3 DITROPAN XL

tolterodine Tier 3 DETROL VAGINAL ANTI-INFECTIVES

terconazole Tier 1

clindamycin crm Tier 3 CLEOCIN metronidazole Tier 3 METROGEL-VAGINAL

MISCELLANEOUS bethanechol Tier 3 URECHOLINE

potassium citrate ext-rel Tier 3 UROCIT-K

HEMATOLOGIC

Guidelines of treatment and management of hemophilia are available at: https://www.hemophilia.org ANTICOAGULANTS CHEST guidelines are available at: https://www.chestnet.org/Guidelines-and-Resources/CHEST-Guideline-Topic-Areas/Pulmonary-Vascular Injectable

enoxaparin Tier 1 dalteparin Tier 3 FRAGMIN

Oral warfarin Tier 1

apixaban Tier 2 ELIQUIS

rivaroxaban Tier 2 XARELTO Synthetic Heparinoid-like Agents

fondaparinux Tier 3 ARIXTRA HEMATOPOIETIC GROWTH FACTORS Guidelines for the management of neutropenia are available at: https://www.asco.org Guidelines for the management of anemia associated with chronic kidney disease are available at: https://www.kidney.org/professionals/guidelines#guidelines darbepoetin alfa Tier 2 ARANESP

epoetin alfa-epbx Tier 2 RETACRIT

filgrastim-aafi Tier 2 NIVESTYM

pegfilgrastim Tier 2 NEULASTA pegfilgrastim-cbqv Tier 2 UDENYCA

Page 32: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

32

HEMOPHILIA A AGENTS

antihemophilic factor (recombinant) Tier 2 KOGENATE FS antihemophilic factor (recombinant) Tier 2 KOVALTRY

antihemophilic factor (recombinant) Tier 2 NOVOEIGHT

antihemophilic factor (recombinant) pegylated Tier 2 ADYNOVATE

antihemophilic factor (recombinant) pegylated-aucl Tier 2 JIVI human coagulation factor VIII (rDNA) simoctocog alfa Tier 2 NUWIQ

HEMOPHILIA B AGENTS coagulation factor IX (recombinant) glycopegylated Tier 2 REBINYN

IDIOPATHIC THROMBOCYTOPENIC PURPURA AGENTS eltrombopag Tier 3 PROMACTA

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AGENTS eculizumab Tier 3 SOLIRIS

PLATELET AGGREGATION INHIBITORS clopidogrel Tier 1

dipyridamole Tier 1

prasugrel Tier 1 ticagrelor Tier 2 BRILINTA

dipyridamole ext-rel/aspirin Tier 3 AGGRENOX

PLATELET SYNTHESIS INHIBITORS anagrelide Tier 3 AGRYLIN

STEM CELL MOBILIZERS plerixafor Tier 3 MOZOBIL

THROMBOCYTOPENIA AGENTS lusutrombopag Tier 2 MULPLETA

MISCELLANEOUS cilostazol Tier 1

IMMUNOLOGIC AGENTS

Guidelines for the management of rheumatic diseases are available at: https://www.rheumatology.org ALLERGENIC EXTRACTS grass mixed pollen allergen extract Tier 2 ORALAIR

ragweed pollen allergen extract Tier 2 RAGWITEK

timothy grass pollen allergen extract Tier 2 GRASTEK

AUTOIMMUNE AGENTS ‡

adalimumab Tier 2 HUMIRA

apremilast Tier 2 OTEZLA etanercept Tier 2 ENBREL

guselkumab Tier 2 TREMFYA

risankizumab-rzaa Tier 2 SKYRIZI secukinumab Tier 2 COSENTYX

tofacitinib Tier 2 XELJANZ

tofacitinib ext-rel Tier 2 XELJANZ XR upadacitinib Tier 2 RINVOQ

ustekinumab Tier 2 STELARA SUBCUTANEOUS

‡ Coverage may be altered or copay amounts may vary based on the condition being treated (e.g., psoriasis).

Page 33: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

33

DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs)

methotrexate Tier 1 methotrexate auto-injector Tier 2 RASUVO

hydroxychloroquine Tier 3 PLAQUENIL

leflunomide Tier 3 ARAVA

HEREDITARY ANGIOEDEMA

C1 esterase inhibitor, recombinant Tier 2 RUCONEST

icatibant Tier 2 FIRAZYR IMMUNOMODULATORS CDC recommendations on the treatment of hepatitis are available at: https://www.cdc.gov/hepatitis/Resources/ Guidelines for the management of hepatitis are available at: https://www.aasld.org Interferons

interferon alfa-2b Tier 3 INTRON A

peginterferon alfa-2a Tier 3 PEGASYS peginterferon alfa-2b Tier 3 SYLATRON

Miscellaneous canakinumab Tier 3 ILARIS

IMMUNOSUPPRESSANTS Antimetabolites

mycophenolate mofetil Tier 1

mycophenolate sodium delayed-rel Tier 1 azathioprine Tier 3 AZASAN

azathioprine Tier 3 IMURAN

Calcineurin Inhibitors

cyclosporine Tier 1

cyclosporine, modified Tier 1

tacrolimus Tier 1 Rapamycin Derivatives

sirolimus Tier 1

NUTRITIONAL/SUPPLEMENTS

ELECTROLYTES Potassium potassium chloride ext-rel Tier 1

potassium chloride liquid Tier 1

VITAMINS AND MINERALS Folic Acid/Combinations

folic acid Tier 1

folic acid/vitamin B6/vitamin B12 Tier 1 Prenatal Vitamins

prenatal vitamins Tier 1 prenatal vitamins/DHA/docusate/folic acid Tier 2 CITRANATAL 90 DHA

prenatal vitamins/DHA/docusate/folic acid Tier 2 CITRANATAL DHA

prenatal vitamins/DHA/docusate/folic acid Tier 2 CITRANATAL HARMONY prenatal vitamins/docusate/folic acid Tier 2 CITRANATAL RX

Page 34: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

34

prenatal vitamins/docusate/folic acid + DHA Tier 2 CITRANATAL ASSURE

prenatal vitamins/folic acid + pyridoxine Tier 2 CITRANATAL B-CALM Miscellaneous

cyanocobalamin inj Tier 1

ergocalciferol (D2) Tier 1 fluoride drops Tier 1

fluoride tabs Tier 1

multivitamins/fluoride drops, tabs Tier 1 multivitamins/fluoride/iron drops, tabs Tier 1

vitamin ADC/fluoride drops Tier 1

vitamin ADC/fluoride/iron drops Tier 1

RESPIRATORY

Guidelines to the management, prevention, or treatment of COPD and asthma are available at: https://www.aaaai.org https://ginasthma.org https://goldcopd.org https://www.nhlbi.nih.gov The Allergy Report and guidelines for allergy-related conditions are available at: https://www.aaaai.org ANAPHYLAXIS TREATMENT AGENTS

epinephrine auto-injector Tier 1 epinephrine auto-injector Tier 2 EPIPEN

epinephrine auto-injector Tier 2 EPIPEN JR.

ANTICHOLINERGICS

ipratropium soln Tier 1

tiotropium Tier 2 SPIRIVA umeclidinium bromide Tier 2 INCRUSE ELLIPTA

ANTICHOLINERGIC/BETA AGONIST COMBINATIONS Short Acting

ipratropium/albuterol soln Tier 1

Long Acting

glycopyrrolate/formoterol Tier 2 BEVESPI AEROSPHERE

tiotropium/olodaterol Tier 2 STIOLTO RESPIMAT

umeclidinium/vilanterol Tier 2 ANORO ELLIPTA ANTICHOLINERGIC/BETA AGONIST/STEROID INHALANT COMBINATIONS

fluticasone/umeclidinium/vilanterol Tier 2 TRELEGY ELLIPTA ANTIHISTAMINES, LOW SEDATING

levocetirizine Tier 1 ANTIHISTAMINES, SEDATING

clemastine 2.68 mg Tier 1 cyproheptadine Tier 1

hydroxyzine HCl Tier 1

Page 35: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

35

ANTITUSSIVES Clinical practice guidelines are available at: https://journal.chestnet.org/article/S0012-3692(15)52856-0/pdf

* benzonatate Tier 3 TESSALON * Listing does not include NDCs 69336012615 and 69499032915. Drug products are identified by unique numerical product identifiers, called National Drug Codes (NDC), which identify the manufacturer, strength, dosage form, formulation and package size. ANTITUSSIVE COMBINATIONS Opioid

codeine/guaifenesin liquid Tier 1 codeine/guaifenesin/pseudoephedrine Tier 1

codeine/promethazine Tier 1

codeine/promethazine/phenylephrine Tier 1

hydrocodone/homatropine Tier 1 Non-opioid

dextromethorphan/brompheniramine/pseudoephedrine Tier 1 dextromethorphan/promethazine Tier 1

BETA AGONISTS Inhalants Short Acting

albuterol soln Tier 1 albuterol sulfate, CFC-free aerosol Tier 1

levalbuterol tartrate, CFC-free aerosol Tier 1

Long Acting Hand-held Active Inhalation

olodaterol, CFC-free aerosol Tier 2 STRIVERDI RESPIMAT salmeterol xinafoate Tier 2 SEREVENT

Nebulized Passive Inhalation formoterol inhalation soln Tier 2 PERFOROMIST

Oral Agents albuterol Tier 1

albuterol ext-rel Tier 1

terbutaline Tier 1 CYSTIC FIBROSIS

tobramycin inhalation soln Tier 1

tobramycin inhalation soln Tier 2 BETHKIS dornase alfa Tier 3 PULMOZYME

LEUKOTRIENE MODULATORS montelukast Tier 1

zafirlukast Tier 1

zileuton ext-rel Tier 1 MAST CELL STABILIZERS

cromolyn soln Tier 1

Page 36: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

36

NASAL ANTIHISTAMINES

azelastine spray Tier 1 azelastine spray Tier 3 ASTEPRO

olopatadine spray Tier 3 PATANASE

NASAL STEROIDS/COMBINATIONS

flunisolide spray Tier 1

fluticasone spray Tier 1

mometasone spray Tier 1 azelastine/fluticasone spray Tier 2 DYMISTA

PHOSPHODIESTERASE-4 INHIBITORS roflumilast Tier 2 DALIRESP

PULMONARY ENZYME DEFICIENCY AGENTS alpha-1 proteinase inhibitor Tier 2 PROLASTIN-C

PULMONARY FIBROSIS AGENTS nintedanib Tier 2 OFEV

pirfenidone Tier 2 ESBRIET

SEVERE ASTHMA AGENTS

benralizumab Tier 2 FASENRA

dupilumab Tier 2 DUPIXENT

mepolizumab Tier 2 NUCALA omalizumab Tier 2 XOLAIR

STEROID/BETA AGONIST COMBINATIONS budesonide/formoterol Tier 2 SYMBICORT

fluticasone/salmeterol Tier 2 ADVAIR DISKUS

fluticasone/salmeterol, CFC-free aerosol Tier 2 ADVAIR HFA fluticasone/vilanterol Tier 2 BREO ELLIPTA

STEROID INHALANTS beclomethasone breath-activated aerosol Tier 2 QVAR REDIHALER

budesonide Tier 2 PULMICORT FLEXHALER

fluticasone Tier 2 ARNUITY ELLIPTA

fluticasone Tier 2 FLOVENT DISKUS fluticasone, CFC-free aerosol Tier 2 FLOVENT HFA

budesonide inhalation susp Tier 3 PULMICORT RESPULES

XANTHINES

theophylline ext-rel tabs Tier 1

MISCELLANEOUS

ipratropium spray Tier 1

TOPICAL

DERMATOLOGY Acne Guidelines for the care and treatment of acne vulgaris are available at: https://www.aad.org/practicecenter/quality/clinical-guidelines Oral isotretinoin Tier 1

Page 37: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

37

Topical

adapalene Tier 1 clindamycin gel Tier 1

clindamycin/benzoyl peroxide Tier 1

erythromycin gel 2% Tier 1

erythromycin soln Tier 1 tretinoin Tier 1

tretinoin - Avita Tier 1

tretinoin gel microsphere Tier 1 adapalene/benzoyl peroxide Tier 2 EPIDUO

adapalene/benzoyl peroxide Tier 2 EPIDUO FORTE

tazarotene Tier 2 TAZORAC benzoyl peroxide Tier 3 BENZAC AC

clindamycin gel, lotion, soln Tier 3 CLEOCIN T

clindamycin/benzoyl peroxide Tier 3 DUAC

erythromycin/benzoyl peroxide Tier 3 BENZAMYCIN sulfacetamide lotion 10% Tier 3 KLARON

tretinoin Tier 3 RETIN-A

Actinic Keratosis

fluorouracil crm 5%, soln 5%, soln 2% Tier 1

fluorouracil crm 4% Tier 2 TOLAK imiquimod Tier 2 ZYCLARA

ingenol mebutate Tier 2 PICATO

Antibiotics

gentamicin Tier 1

mupirocin oint Tier 1

silver sulfadiazine Tier 3 SILVADENE Antifungals

clotrimazole Tier 1 econazole Tier 1

ketoconazole crm 2% Tier 1

luliconazole Tier 1 nystatin Tier 1

naftifine Tier 2 NAFTIN

ciclopirox Tier 3 LOPROX

Antipsoriatics Guidelines of care for the management and treatment of psoriasis with topical therapies are available at: https://www.aad.org Oral acitretin Tier 3 SORIATANE

methoxsalen oral Tier 3 OXSORALEN-ULTRA

Topical

calcipotriene oint, soln 0.005% Tier 1

Antiseborrheics

selenium sulfide lotion 2.5% Tier 1

ketoconazole shampoo 2% Tier 3 NIZORAL

Page 38: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

38

Atopic Dermatitis Guidelines for the treatment of atopic dermatitis are available at: https://www.aad.org/practicecenter/quality/clinical-guidelines Injectable

dupilumab Tier 2 DUPIXENT

Topical pimecrolimus Tier 1

tacrolimus Tier 1

crisaborole Tier 2 EUCRISA Corticosteroids Low Potency alclometasone crm, oint 0.05% Tier 1

fluocinolone acetonide soln 0.01% Tier 1

hydrocortisone crm 2.5% Tier 1 hydrocortisone lotion 1% Tier 1

desonide crm, lotion, oint 0.05% Tier 3 DESOWEN

Medium Potency

betamethasone valerate crm, lotion, oint 0.1% Tier 1

desoximetasone crm, oint 0.05% Tier 1

fluocinolone acetonide crm, oint 0.025% Tier 1 fluticasone propionate crm, lotion 0.05%, oint 0.005% Tier 1

hydrocortisone butyrate crm, oint, soln 0.1% Tier 1

hydrocortisone valerate crm, oint 0.2% Tier 1 triamcinolone acetonide crm, lotion 0.025% Tier 1

triamcinolone acetonide crm, lotion, oint 0.1% Tier 1

mometasone crm, lotion, oint 0.1% Tier 3 ELOCON High Potency

betamethasone dipropionate crm, lotion, oint 0.05% Tier 1

desoximetasone crm, oint 0.25%, gel 0.05% Tier 1 fluocinonide crm, gel, oint, soln 0.05% Tier 1

triamcinolone acetonide crm 0.5% Tier 1

betamethasone dipropionate augmented crm 0.05% Tier 3 DIPROLENE AF betamethasone dipropionate augmented lotion 0.05% Tier 3 DIPROLENE

Very High Potency clobetasol propionate foam 0.05% Tier 1

betamethasone dipropionate augmented gel, oint 0.05% Tier 3 DIPROLENE

clobetasol propionate crm, gel, oint, soln 0.05% Tier 3 TEMOVATE clobetasol propionate lotion, shampoo 0.05% Tier 3 CLOBEX

halobetasol propionate crm, oint 0.05% Tier 3 ULTRAVATE

Emollients ammonium lactate 12% Tier 3 LAC-HYDRIN

Local Analgesics lidocaine patch Tier 3 LIDODERM

Local Anesthetics lidocaine/prilocaine Tier 1

Rosacea azelaic acid gel Tier 1

doxycycline monohydrate delayed-rel caps Tier 1

Page 39: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

39

metronidazole gel 0.75% Tier 1

azelaic acid foam Tier 2 FINACEA FOAM ivermectin Tier 2 SOOLANTRA

metronidazole crm 0.75% Tier 3 METROCREAM

metronidazole gel 1% Tier 3 METROGEL

metronidazole lotion 0.75% Tier 3 METROLOTION Scabicides and Pediculicides

permethrin 5% Tier 1 malathion Tier 3 OVIDE

Miscellaneous Skin and Mucous Membrane imiquimod Tier 1

podofilox Tier 3 CONDYLOX

MOUTH/THROAT/DENTAL AGENTS Anesthetics - Topical Oral

lidocaine viscous Tier 1 Protectants - Mouth/Throat

benzyl alcohol/carbomer 941/glycerin Tier 2 MUGARD soy phospholipid/glycerol dioleate Tier 2 EPISIL

Steroids - Mouth/Throat

triamcinolone paste Tier 1 OPHTHALMIC Preferred Practice Pattern Guidelines for the treatment of various ophthalmic conditions are available at: https://one.aao.org Antiallergics

azelastine Tier 1

cromolyn sodium Tier 1 alcaftadine Tier 2 LASTACAFT

olopatadine Tier 2 PAZEO

olopatadine Tier 3 PATADAY

olopatadine Tier 3 PATANOL Anti-infectives

bacitracin Tier 1 erythromycin Tier 1

gentamicin Tier 1

levofloxacin Tier 1 neomycin/polymyxin B/gramicidin Tier 1

polymyxin B/bacitracin Tier 1

sulfacetamide oint 10% Tier 1

besifloxacin Tier 2 BESIVANCE ciprofloxacin oint Tier 2 CILOXAN

moxifloxacin Tier 2 MOXEZA

ciprofloxacin soln Tier 3 CILOXAN moxifloxacin Tier 3 VIGAMOX

ofloxacin Tier 3 OCUFLOX

polymyxin B/trimethoprim Tier 3 POLYTRIM sulfacetamide soln 10% Tier 3 BLEPH-10

tobramycin Tier 3 TOBREX

Page 40: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

40

Anti-infective/Anti-inflammatory Combinations

neomycin/polymyxin B/bacitracin/hydrocortisone oint Tier 1 neomycin/polymyxin B/hydrocortisone susp Tier 1

sulfacetamide/prednisolone phosphate 10%/0.25% Tier 1

tobramycin/dexamethasone oint 0.3%/0.1% Tier 2 TOBRADEX

tobramycin/dexamethasone susp 0.3%/0.05% Tier 2 TOBRADEX ST neomycin/polymyxin B/dexamethasone Tier 3 MAXITROL

tobramycin/dexamethasone susp 0.3%/0.1% Tier 3 TOBRADEX

Anti-inflammatories Nonsteroidal

bromfenac sodium Tier 1 diclofenac sodium Tier 1

ketorolac tromethamine Tier 2 ACUVAIL

nepafenac Tier 2 ILEVRO nepafenac Tier 2 NEVANAC

ketorolac Tier 3 ACULAR

Steroidal

dexamethasone sodium phosphate Tier 1

fluorometholone Tier 1

loteprednol Tier 1 prednisolone acetate 1% Tier 1

dexamethasone Tier 2 MAXIDEX

difluprednate Tier 2 DUREZOL fluorometholone Tier 2 FML FORTE

fluorometholone Tier 2 FML S.O.P.

prednisolone acetate Tier 2 PRED MILD prednisolone phosphate 1% Tier 3

Antivirals

trifluridine Tier 1 Beta-blockers Nonselective

levobunolol Tier 1

timolol maleate gel Tier 1

timolol hemihydrate Tier 2 BETIMOL timolol maleate Tier 3 TIMOPTIC

Selective betaxolol Tier 2 BETOPTIC S

Carbonic Anhydrase Inhibitors Topical

brinzolamide Tier 2 AZOPT

dorzolamide Tier 3 TRUSOPT Carbonic Anhydrase Inhibitor/Beta-blocker Combinations

dorzolamide/timolol maleate Tier 3 COSOPT Carbonic Anhydrase Inhibitor/Sympathomimetic Combinations

brinzolamide/brimonidine Tier 2 SIMBRINZA Dry Eye Disease

cyclosporine, emulsion Tier 2 RESTASIS lifitegrast Tier 2 XIIDRA

Page 41: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

41

Prostaglandins

bimatoprost Tier 2 LUMIGAN travoprost Tier 2 TRAVATAN Z

latanoprost Tier 3 XALATAN

Retinal Disorders

aflibercept Tier 2 EYLEA

ranibizumab Tier 2 LUCENTIS

Rho Kinase Inhibitors

netarsudil Tier 2 RHOPRESSA

Rho Kinase Inhibitor/Prostaglandin Combinations

netarsudil/latanoprost Tier 2 ROCKLATAN

Sympathomimetics

brimonidine 0.2% Tier 1

brimonidine Tier 2 ALPHAGAN P Sympathomimetic/Beta-blocker Combinations

brimonidine/timolol Tier 2 COMBIGAN OTIC Clinical practice guidelines for the treatment of otitis media are available at: https://www.aap.org Anti-infectives

acetic acid Tier 1

ofloxacin otic Tier 1

Anti-infective/Anti-inflammatory Combinations

neomycin/polymyxin B/hydrocortisone Tier 1

ciprofloxacin/dexamethasone Tier 2 CIPRODEX

Page 42: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

42

WEBSITES

Agency for Healthcare Research and Quality https://www.ahrq.gov Alzheimer's Association https://www.alz.org American Academy of Allergy, Asthma and Immunology https://www.aaaai.org American Academy of Child & Adolescent Psychiatry https://www.aacap.org American Academy of Dermatology https://www.aad.org American Academy of Neurology https://www.aan.com American Academy of Ophthalmology https://www.aao.org American Academy of Pediatrics https://www.aap.org American Association for the Study of Liver Disease https://www.aasld.org American Association of Clinical Endocrinologists https://www.aace.com American Association of Diabetes Educators https://www.diabeteseducator.org American Cancer Society https://www.cancer.org American College of Allergy, Asthma and Immunology https://www.acaai.org American College of Cardiology https://www.acc.org American College of Chest Physicians https://www.chestnet.org American College of Gastroenterology https://gi.org American College of Physicians https://www.acponline.org American College of Rheumatology https://www.rheumatology.org

American Congress of Obstetricians and Gynecologists https://www.acog.org American Diabetes Association http://www.diabetes.org American Gastroenterological Association https://www.gastro.org American Headache Society Committee for Headache Education https://americanheadachesociety.org American Heart Association https://professional.heart.org American Lung Association https://www.lung.org American Medical Association https://www.ama-assn.org American Psychiatric Association https://www.psychiatry.org American Society of Anesthesiologists https://www.asahq.org American Society of Clinical Oncology https://www.asco.org American Society of Interventional Pain Physicians https://www.asipp.org American Urological Association https://www.auanet.org Centers for Disease Control and Prevention https://www.cdc.gov Centers for Disease Control and Prevention Guideline topics: AIDS https://www.cdc.gov/hiv/default.html Centers for Disease Control and Prevention Guideline topics: Sexually Transmitted Diseases https://www.cdc.gov/std/treatment/default.htm CVS Caremark https://www.caremark.com The Food and Drug Administration https://www.fda.gov

Page 43: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

43

Global Initiative for Asthma https://ginasthma.org Infectious Diseases Society of America https://www.idsociety.org Institute for Safe Medication Practices https://www.ismp.org Johns Hopkins AIDS Service https://www.thebody.com/content/art12096.html Juvenile Diabetes Research Foundation International https://www.jdrf.org MedWatch https://www.fda.gov/Safety/MedWatch/default.htm National Agricultural Library https://www.nal.usda.gov National Cancer Institute https://www.cancer.gov/about-cancer National Comprehensive Cancer Network https://www.nccn.org

National Foundation for Infectious Diseases http://www.nfid.org National Guideline Clearinghouse https://www.ahrq.gov National Heart, Lung and Blood Institute https://www.nhlbi.nih.gov National Institutes of Health https://www.nih.gov National Kidney Foundation https://www.kidney.org National Osteoporosis Foundation https://www.nof.org North American Menopause Society https://www.menopause.org United States Department of Health and Human Services https://www.hhs.gov World Health Organization https://www.who.int

Page 44: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

44

INDEX

A abacavir tabs, 10 abacavir/dolutegravir/lamivudine, 9 abacavir/lamivudine, 10 abaloparatide, 25 ABILIFY MAINTENA, 20 abiraterone, 12 acamprosate calcium, 22 acarbose, 23 ACCU-CHEK AVIVA PLUS kits and test strips, 24 ACCU-CHEK COMPACT PLUS kits and test strips, 24 ACCU-CHEK GUIDE kits and test strips, 24 ACCU-CHEK SMARTVIEW kits and test strips, 24 ACCUPRIL, 13 ACCURETIC, 13 acetazolamide, 16 acetazolamide ext-rel, 16 acetic acid, 41 acitretin, 37 ACTIGALL, 29 ACTONEL, 25 ACTOPLUS MET, 24 ACULAR, 40 ACUVAIL, 40 acyclovir caps, tabs, 11 ADALAT CC, 16 adalimumab, 32 adapalene, 37 adapalene/benzoyl peroxide, 37 ADEMPAS, 17 ADVAIR DISKUS, 36 ADVAIR HFA, 36 ADYNOVATE, 32 AFINITOR, 12 aflibercept, 41 AGGRENOX, 32 AGRYLIN, 32 AIMOVIG, 21 AJOVY, 21 albuterol, 35 albuterol ext-rel, 35 albuterol soln, 35 albuterol sulfate, CFC-free aerosol, 35 alcaftadine, 39 alclometasone crm, oint 0.05%, 38 ALDACTAZIDE, 17 ALDACTONE, 13 alendronate, 25 alfuzosin ext-rel, 30 aliskiren, 16 aliskiren/hydrochlorothiazide, 16 ALKERAN, 11 allopurinol, 7 alosetron, 29 alpha-1 proteinase inhibitor, 36 ALPHAGAN P, 41 alprazolam, 18 alprostadil supp, 30 ALTACE, 13 amantadine, 19 AMARYL, 24 AMBIEN, 21

AMBIEN CR, 21 ambrisentan, 17 amiloride, 16 amiloride/hydrochlorothiazide, 17 amiodarone, 14 AMITIZA, 29 amitriptyline, 19 amlodipine, 16 amlodipine/atorvastatin, 16 amlodipine/benazepril, 13 amlodipine/olmesartan, 14 amlodipine/telmisartan, 14 amlodipine/valsartan, 14 amlodipine/valsartan/hydrochlorothiazide, 14 ammonium lactate 12%, 38 amoxicillin, 9 amoxicillin/clavulanate, 9 amoxicillin/clavulanate ext-rel, 9 amphetamine/dextroamphetamine mixed salts, 20 amphetamine/dextroamphetamine mixed salts ext-rel, 20 ampicillin, 9 ANAFRANIL, 18 anagrelide, 32 anastrozole, 12 ANDRODERM, 23 ANORO ELLIPTA, 34 ANTABUSE, 22 ANTARA, 15 antihemophilic factor (recombinant), 32 antihemophilic factor (recombinant) pegylated, 32 antihemophilic factor (recombinant) pegylated-aucl, 32 ANUSOL-HC, 30 apalutamide, 12 apixaban, 31 apremilast, 32 APRISO, 29 ARANESP, 31 ARAVA, 33 ARICEPT, 19 ARIMIDEX, 12 aripiprazole, 20 aripiprazole ext-rel inj, 20 aripiprazole lauroxil ext-rel inj, 20 ARISTADA, 20 ARISTADA INITIO, 20 ARIXTRA, 31 armodafinil, 22 ARNUITY ELLIPTA, 36 AROMASIN, 12 ASTEPRO, 36 atazanavir, 10 atazanavir/cobicistat, 9 ATELVIA, 25 atenolol, 15 atenolol/chlorthalidone, 16 ATIVAN, 18 atomoxetine, 20 atorvastatin, 15 atovaquone/proguanil, 9 ATRIPLA, 9 AUBAGIO, 22 AUGMENTIN, 9 AUSTEDO, 22

Page 45: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

45

AVELOX, 9 AVODART, 30 AYGESTIN, 28 AZASAN, 33 azathioprine, 33 azelaic acid foam, 39 azelaic acid gel, 38 azelastine, 39 azelastine spray, 36 azelastine/fluticasone spray, 36 azithromycin, 9 AZOPT, 40 AZOR, 14 AZULFIDINE, 29 AZULFIDINE EN-TABS, 29

B bacitracin, 39 baclofen, 22 balsalazide, 29 BARACLUDE, 11 BASAGLAR, 24 BD ULTRAFINE insulin syringes and needles, 24 beclomethasone breath-activated aerosol, 36 BELBUCA, 7 BELSOMRA, 21 benazepril, 13 benazepril/hydrochlorothiazide, 13 benralizumab, 36 BENTYL, 29 BENZAC AC, 37 BENZAMYCIN, 37 benzonatate, 35 benzoyl peroxide, 37 benztropine, 19 benzyl alcohol/carbomer 941/glycerin, 39 besifloxacin, 39 BESIVANCE, 39 betamethasone dipropionate augmented crm 0.05%, 38 betamethasone dipropionate augmented gel, oint 0.05%, 38 betamethasone dipropionate augmented lotion 0.05%, 38 betamethasone dipropionate crm, lotion, oint 0.05%, 38 betamethasone valerate crm, lotion, oint 0.1%, 38 BETASERON, 22 betaxolol, 40 bethanechol, 31 BETHKIS, 35 BETIMOL, 40 BETOPTIC S, 40 BEVESPI AEROSPHERE, 34 bexarotene caps, 13 bicalutamide, 12 bictegravir/emtricitabine/tenofovir alafenamide, 9 BIDIL, 17 BIKTARVY, 9 bimatoprost, 41 bismuth/metronidazole/tetracycline, 30 bisoprolol, 15 bisoprolol/hydrochlorothiazide, 16 BLEPH-10, 39 blood glucose continuous monitoring receivers, sensors,

transmitters, 24 blood glucose monitoring kits, test strips, 24 BONIVA, 25 bosentan, 17 BOSULIF, 12

bosutinib, 12 BREO ELLIPTA, 36 BRILINTA, 32 brimonidine, 41 brimonidine 0.2%, 41 brimonidine/timolol, 41 brinzolamide, 40 brinzolamide/brimonidine, 40 bromfenac sodium, 40 bromocriptine, 20 budesonide, 36 budesonide delayed-rel caps, 29 budesonide ext-rel, 29 budesonide inhalation susp, 36 budesonide/formoterol, 36 bumetanide, 16 buprenorphine, 7 buprenorphine transdermal, 7 buprenorphine/naloxone sublingual, 22 buprenorphine/naloxone sublingual tabs, 22 bupropion, 19 bupropion ext-rel, 19, 23 buspirone, 18 busulfan, 11 butalbital/acetaminophen/caffeine tabs, 8 butalbital/aspirin/caffeine, 8 BYSTOLIC, 15

C C1 esterase inhibitor, recombinant, 33 cabergoline, 28 CABOMETYX, 12 cabozantinib, 12 CADUET, 16 CALAN SR, 16 calcipotriene oint, soln 0.005%, 37 calcitonin-salmon spray, 25 calcitriol (1,25-D3), 28 calcium acetate, 28 canakinumab, 33 candesartan, 14 candesartan/hydrochlorothiazide, 14 capecitabine, 11 captopril, 13 captopril/hydrochlorothiazide, 13 carbamazepine, 18 carbamazepine ext-rel, 18 CARBATROL, 18 carbidopa/levodopa, 20 carbidopa/levodopa ext-rel, 20 carbidopa/levodopa orally disintegrating tabs, 19 carbidopa/levodopa/entacapone, 20 CARDURA, 14 cariprazine, 20 carisoprodol, 22 carvedilol, 15 carvedilol phosphate ext-rel, 15 CASODEX, 12 CATAPRES, 13 CATAPRES-TTS, 13 cefadroxil, 8 cefdinir, 9 cefixime, 9 cefprozil, 9 cefuroxime axetil, 9 CELEBREX, 7

Page 46: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

46

celecoxib, 7 CELEXA, 19 cephalexin, 8 CERDELGA, 27 CEREZYME, 27 cetrorelix, 27 CETROTIDE, 27 cevimeline, 30 CHANTIX, 23 chlorambucil, 11 chloroquine, 9 chlorpromazine, 20 chlorthalidone, 16 chlorzoxazone, 22 cholestyramine, 15 choriogonadotropin alfa, 27 ciclopirox, 37 cilostazol, 32 CILOXAN, 39 CIMDUO, 10 cimetidine, 29 cinacalcet, 25 CIPRO, 9 CIPRODEX, 41 ciprofloxacin, 9 ciprofloxacin oint, 39 ciprofloxacin soln, 39 ciprofloxacin/dexamethasone, 41 citalopram, 19 CITRANATAL 90 DHA, 33 CITRANATAL ASSURE, 34 CITRANATAL B-CALM, 34 CITRANATAL DHA, 33 CITRANATAL HARMONY, 33 CITRANATAL RX, 33 clarithromycin, 9 clarithromycin ext-rel, 9 clemastine 2.68 mg, 34 CLEOCIN, 11, 31 CLEOCIN T, 37 CLIMARA, 26 CLIMARA PRO, 27 clindamycin, 11 clindamycin crm, 31 clindamycin gel, 37 clindamycin gel, lotion, soln, 37 clindamycin/benzoyl peroxide, 37 clobazam, 18 clobetasol propionate crm, gel, oint, soln 0.05%, 38 clobetasol propionate foam 0.05%, 38 clobetasol propionate lotion, shampoo 0.05%, 38 CLOBEX, 38 clomiphene, 27 clomipramine, 18 clonazepam, 18 clonidine, 13 clonidine transdermal, 13 clopidogrel, 32 clotrimazole, 37 clotrimazole troches, 9 clozapine, 20 CLOZARIL, 20 coagulation factor IX (recombinant) glycopegylated, 32 codeine/acetaminophen, 7 codeine/guaifenesin liquid, 35 codeine/guaifenesin/pseudoephedrine, 35

codeine/promethazine, 35 codeine/promethazine/phenylephrine, 35 colchicine, 7 colesevelam, 15 COLESTID, 15 colestipol, 15 COMBIGAN, 41 COMBIPATCH, 27 COMBIVIR, 10 COMPLERA, 10 COMTAN, 20 CONCERTA, 20 CONDYLOX, 39 conjugated estrogens/bazedoxifene, 27 COPAXONE, 22 COREG, 15 CORGARD, 15 CORLANOR, 17 CORTEF, 27 CORTIFOAM, 29 COSENTYX, 32 COSOPT, 40 COZAAR, 14 CREON, 30 CRINONE, 28 crisaborole, 38 cromolyn sodium, 39 cromolyn soln, 35 cyanocobalamin inj, 34 cyclobenzaprine, 22 cyclophosphamide caps, 11 cyclosporine, 33 cyclosporine, emulsion, 40 cyclosporine, modified, 33 cyproheptadine, 34 CYTOMEL, 28 CYTOTEC, 30

D D.H.E. 45, 21 DALIRESP, 36 dalteparin, 31 danazol, 26 DANTRIUM, 22 dantrolene, 22 dapagliflozin, 24 dapagliflozin/metformin ext-rel, 24 dapsone, 11 darbepoetin alfa, 31 darifenacin ext-rel, 31 darolutamide, 12 darunavir, 10 darunavir/cobicistat, 9 dasatinib, 12 DAYPRO, 7 DDAVP, 28 denosumab, 25 DEPAKENE, 18 DEPAKOTE, 18 DEPAKOTE ER, 18 DEPO-PROVERA, 26 DESCOVY, 10 desipramine, 19 desmopressin spray, tabs, 28 desogestrel/EE, 26 desogestrel/EE 0.15/30, 25

Page 47: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

47

desonide crm, lotion, oint 0.05%, 38 DESOWEN, 38 desoximetasone crm, oint 0.05%, 38 desoximetasone crm, oint 0.25%, gel 0.05%, 38 desvenlafaxine ext-rel, 19 DETROL, 31 deutetrabenazine, 22 dexamethasone, 27, 40 dexamethasone sodium phosphate, 40 DEXCOM CONTINUOUS GLUCOSE MONITORING SYSTEM, 24 DEXEDRINE SPANSULE, 20 DEXILANT, 30 dexlansoprazole delayed-rel, 30 dexmethylphenidate, 20 dexmethylphenidate ext-rel, 20 dextroamphetamine, 20 dextroamphetamine ext-rel, 20 dextromethorphan/brompheniramine/pseudoephedrine, 35 dextromethorphan/promethazine, 35 dextromethorphan/quinidine, 22 DIASTAT, 18 diazepam, 18 diazepam rectal gel, 18 diclofenac sodium, 40 diclofenac sodium delayed-rel, 7 diclofenac sodium delayed-rel/misoprostol, 7 diclofenac sodium gel 1%, 7 diclofenac sodium soln, 7 dicloxacillin, 9 dicyclomine, 29 didanosine delayed-rel, 10 DIFICID, 9 DIFLUCAN, 9 diflunisal, 7 difluprednate, 40 digoxin 0.0625 mg, 0.1875 mg, 16 digoxin 0.125 mg, 0.25 mg, 16 digoxin ped elixir, 16 dihydroergotamine inj, 21 DILANTIN, 18 DILANTIN INFATABS, 18 DILAUDID, 8 diltiazem ext-rel, 16 dimethyl fumarate delayed-rel, 22 diphenoxylate/atropine, 28 DIPROLENE, 38 DIPROLENE AF, 38 dipyridamole, 32 dipyridamole ext-rel/aspirin, 32 disopyramide, 14 disopyramide ext-rel, 14 disulfiram, 22 DITROPAN XL, 31 divalproex sodium delayed-rel, 18 divalproex sodium ext-rel, 18 DIVIGEL, 26 dofetilide, 14 dolutegravir, 10 donepezil, 19 dornase alfa, 35 dorzolamide, 40 dorzolamide/timolol maleate, 40 doxazosin, 14 doxepin, 19, 21 doxercalciferol, 28 doxycycline hyclate, 9

doxycycline hyclate 20 mg, 9 doxycycline monohydrate delayed-rel caps, 38 doxylamine/pyridoxine delayed-rel, 29 dronabinol, 29 dronedarone, 14 drospirenone/EE 3/20, 25 drospirenone/EE 3/30, 25 drospirenone/EE/levomefolate 3/20 and levomefolate, 25 drospirenone/EE/levomefolate 3/30 and levomefolate, 25 DUAC, 37 DUAVEE, 27 DUETACT, 24 dulaglutide, 23 duloxetine delayed-rel, 19 dupilumab, 36, 38 DUPIXENT, 36, 38 DUREZOL, 40 DUROLANE, 8 dutasteride, 30 dutasteride/tamsulosin, 30 DYAZIDE, 17 DYMISTA, 36

E econazole, 37 eculizumab, 32 EDURANT, 10 EE/norethindrone acetate - Jinteli, 27 efavirenz, 10 efavirenz/emtricitabine/tenofovir disoproxil fumarate, 9 efavirenz/lamivudine/tenofovir disoproxil fumarate, 9, 10 elagolix, 26 eletriptan, 21 ELIGARD, 12 eliglustat, 27 ELIQUIS, 31 ELOCON, 38 eltrombopag, 32 eluxadoline, 29 elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide, 10 elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate, 10 EMBEDA, 8 EMGALITY, 21 empagliflozin, 24 empagliflozin/linagliptin, 24 empagliflozin/metformin, 24 empagliflozin/metformin ext-rel, 24 emtricitabine, 10 emtricitabine/rilpivirine/tenofovir alafenamide, 10 emtricitabine/rilpivirine/tenofovir disoproxil fumarate, 10 emtricitabine/tenofovir alafenamide, 10 emtricitabine/tenofovir disoproxil fumarate, 10 EMTRIVA, 10 EMVERM, 11 enalapril, 13 enalapril/hydrochlorothiazide, 13 ENBREL, 32 ENDOMETRIN, 28 enfuvirtide, 10 enoxaparin, 31 entacapone, 20 entecavir soln, 11 entecavir tabs, 10 ENTRESTO, 17 enzalutamide, 12 EPCLUSA, 11

Page 48: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

48

EPIDUO, 37 EPIDUO FORTE, 37 epinephrine auto-injector, 34 EPIPEN, 34 EPIPEN JR., 34 EPISIL, 39 EPIVIR, 10 eplerenone, 13 epoetin alfa-epbx, 31 epoprostenol sodium, 17 eprosartan, 14 EPZICOM, 10 erenumab-aooe, 21 ergocalciferol (D2), 34 ergotamine/caffeine tabs, 21 ERLEADA, 12 erlotinib, 12 erythromycin, 39 erythromycin delayed-rel, 9 erythromycin ethylsuccinate, 9 erythromycin gel 2%, 37 erythromycin soln, 37 erythromycin stearate, 9 erythromycin/benzoyl peroxide, 37 ESBRIET, 36 escitalopram, 19 ESGIC, 8 esomeprazole delayed-rel, 30 ESTRACE, 26 estradiol, 26 estradiol vaginal crm, 27 estradiol vaginal ring, 27 estradiol vaginal tabs, 27 estradiol/levonorgestrel, 27 estradiol/norethindrone, 27 estradiol/norethindrone acetate, 27 ESTRING, 27 estrogens, conjugated, 26 estrogens, conjugated crm, 27 estrogens, conjugated/medroxyprogesterone, 27 eszopiclone, 21 etanercept, 32 ethambutol, 10 ethosuximide, 18 ethynodiol diacetate/EE 1/35 - Zovia 1/35, 26 etodolac, 7 etonogestrel/EE ring, 26 etoposide, 12 etravirine, 10 EUCRISA, 38 EVAMIST, 26 everolimus, 12 EVISTA, 28 evolocumab, 15 EVOTAZ, 9 EVOXAC, 30 EXELON, 19 exemestane, 12 EYLEA, 41 ezetimibe, 15 ezetimibe/simvastatin, 15

F famciclovir, 11 famotidine, 29 FARXIGA, 24

FASENRA, 36 febuxostat, 7 felodipine ext-rel, 16 FEMARA, 12 fenofibrate, 15 fenofibric acid delayed-rel, 15 fentanyl sublingual spray, 7 fentanyl transdermal, 7 fentanyl transmucosal lozenge, 7 fesoterodine ext-rel, 31 FIASP, 24 fidaxomicin, 9 filgrastim-aafi, 31 FINACEA FOAM, 39 finasteride, 30 fingolimod, 22 FIORINAL, 8 FIRAZYR, 33 FLAGYL, 11 flecainide, 14 FLOLAN, 17 FLOMAX, 30 FLOVENT DISKUS, 36 FLOVENT HFA, 36 fluconazole, 9 fludrocortisone, 27 flunisolide spray, 36 fluocinolone acetonide crm, oint 0.025%, 38 fluocinolone acetonide soln 0.01%, 38 fluocinonide crm, gel, oint, soln 0.05%, 38 fluoride drops, 34 fluoride tabs, 34 fluorometholone, 40 fluorouracil crm 4%, 37 fluorouracil crm 5%, soln 5%, soln 2%, 37 fluoxetine, 19 fluphenazine, 20 flutamide, 12 fluticasone, 36 fluticasone propionate crm, lotion 0.05%, oint 0.005%, 38 fluticasone spray, 36 fluticasone, CFC-free aerosol, 36 fluticasone/salmeterol, 36 fluticasone/salmeterol, CFC-free aerosol, 36 fluticasone/umeclidinium/vilanterol, 34 fluticasone/vilanterol, 36 fluvastatin, 15 fluvoxamine, 18 FML FORTE, 40 FML S.O.P., 40 FOCALIN, 20 FOCALIN XR, 20 folic acid, 33 folic acid/vitamin B6/vitamin B12, 33 follitropin alfa, 27 fondaparinux, 31 formoterol inhalation soln, 35 FORTEO, 25 FOSAMAX, 25 fosinopril, 13 fosinopril/hydrochlorothiazide, 13 FRAGMIN, 31 fremanezumab-vfrm, 21 FURADANTIN, 11 furosemide, 16

Page 49: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

49

FUZEON, 10 FYCOMPA, 18

G gabapentin, 18 gabapentin ext-rel, 22 galantamine, 19 galantamine ext-rel, 19 galcanezumab-gnlm, 21 ganirelix acetate, 27 gefitinib, 12 GEL-ONE, 8 GELSYN-3, 8 gemfibrozil, 15 GENOTROPIN, 27 gentamicin, 37, 39 GENVOYA, 10 GEODON, 20 GILENYA, 22 glatiramer, 22 glimepiride, 24 glipizide, 24 glipizide ext-rel, 24 glipizide/metformin, 23 GLUCAGEN HYPOKIT, 27 GLUCAGON EMERGENCY KIT, 27 glucagon, human recombinant, 27 GLUCOPHAGE, 23 GLUCOPHAGE XR, 23 GLUCOTROL, 24 GLUCOTROL XL, 24 glycopyrrolate/formoterol, 34 GLYXAMBI, 24 GOLYTELY, 30 GONAL-F, 27 GRALISE, 22 granisetron, 29 granisetron transdermal, 29 grass mixed pollen allergen extract, 32 GRASTEK, 32 griseofulvin ultramicrosize, 9 guanfacine, 13 guanfacine ext-rel, 20 guselkumab, 32

H halobetasol propionate crm, oint 0.05%, 38 haloperidol, 20 HARVONI, 11 HECTOROL, 28 human coagulation factor VIII (rDNA) simoctocog alfa, 32 HUMATROPE, 27 HUMIRA, 32 HUMULIN R U-500, 24 HYCAMTIN, 12 hydralazine, 17 HYDREA, 13 hydrochlorothiazide, 16 hydrocodone/acetaminophen, 8 hydrocodone/homatropine, 35 hydrocortisone, 27 hydrocortisone acetate foam, 29 hydrocortisone acetate/pramoxine foam, 30 hydrocortisone butyrate crm, oint, soln 0.1%, 38 hydrocortisone crm, 30 hydrocortisone crm 2.5%, 38 hydrocortisone enema, 29

hydrocortisone lotion 1%, 38 hydrocortisone valerate crm, oint 0.2%, 38 hydromorphone, 8 hydromorphone ext-rel, 7 hydroxychloroquine, 33 hydroxyurea, 13 hydroxyzine HCl, 34 hyoscyamine sulfate, 29 hyoscyamine sulfate ext-rel, 29 hyoscyamine sulfate ext-rel caps, 29 hyoscyamine sulfate orally disintegrating tabs, 29 HYZAAR, 14

I ibandronate, 25 IBRANCE, 12 ibuprofen, 7 icatibant, 33 icosapent ethyl, 15 ILARIS, 33 ILEVRO, 40 imatinib mesylate, 12 imiglucerase, 27 imipramine HCl, 19 imiquimod, 37, 39 IMITREX, 21 IMURAN, 33 INCRUSE ELLIPTA, 34 indapamide, 16 INDERAL LA, 15 ingenol mebutate, 37 INGREZZA, 22 INSPRA, 13 insulin aspart, 24 insulin aspart protamine 70%/insulin aspart 30%, 24 insulin degludec, 24 insulin detemir, 24 insulin glargine, 24 insulin human, 24 insulin infusion disposable pump, 24 insulin isophane human, 24 insulin isophane human 70%/regular 30%, 24 insulin syringes, needles, 24 INTELENCE, 10 interferon alfa-2b, 33 interferon beta-1a, 22 interferon beta-1b, 22 INTRON A, 33 ipratropium soln, 34 ipratropium spray, 36 ipratropium/albuterol soln, 34 irbesartan, 14 irbesartan/hydrochlorothiazide, 14 IRESSA, 12 ISENTRESS, 10 isoniazid, 10 ISORDIL, 17 isosorbide dinitrate ext-rel tabs, 17 isosorbide dinitrate oral, 17 isosorbide dinitrate/hydralazine, 17 isosorbide mononitrate, 17 isosorbide mononitrate ext-rel, 17 isotretinoin, 36 itraconazole, 9 ivabradine, 17 ivermectin, 11, 39

Page 50: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

50

J JANUMET, 23 JANUMET XR, 23 JANUVIA, 23 JARDIANCE, 24 JIVI, 32

K KADIAN, 8 KALETRA, 10 KEFLEX, 8 KEPPRA, 18 KEPPRA XR, 18 ketoconazole crm 2%, 37 ketoconazole shampoo 2%, 37 ketorolac, 40 ketorolac tromethamine, 40 KISQALI, 12 KISQALI FEMARA CO-PACK, 12 KLARON, 37 KLONOPIN, 18 KOGENATE FS, 32 KOVALTRY, 32 KUVAN, 28 KYLEENA, 26

L labetalol, 15 LAC-HYDRIN, 38 lacosamide, 18 lactulose soln, 30 lamivudine, 10 lamivudine/tenofovir disoproxil fumarate, 10 lamivudine/zidovudine, 10 lamotrigine, 18 lamotrigine ext-rel, 18 lamotrigine orally disintegrating tabs, 18 LANOXIN, 16 lanreotide acetate, 23 lansoprazole + amoxicillin + clarithromycin, 30 lansoprazole delayed-rel, 30 lapatinib, 12 LASIX, 16 LASTACAFT, 39 latanoprost, 41 LATUDA, 20 ledipasvir/sofosbuvir, 11 leflunomide, 33 lenalidomide, 12 letrozole, 12 LEUKERAN, 11 leuprolide acetate, 12 levalbuterol tartrate, CFC-free aerosol, 35 LEVAQUIN, 9 LEVBID, 29 LEVEMIR, 24 levetiracetam, 18 levetiracetam ext-rel, 18 levobunolol, 40 levocarnitine, 25 levocetirizine, 34 levofloxacin, 9, 39 levonorgestrel releasing IUD, 26 levonorgestrel/EE - Trivora, 26 levonorgestrel/EE 0.1/20 - Lessina, 25 levonorgestrel/EE 0.1/20 and EE 10, 26

levonorgestrel/EE 0.15/30, 26 levonorgestrel/EE 0.15/30 - Levora, 25 levonorgestrel/EE 0.15/30 and EE 10, 26 levothyroxine, 28 levothyroxine - Levoxyl, 28 LEVSIN, 29 lidocaine patch, 38 lidocaine viscous, 39 lidocaine/prilocaine, 38 LIDODERM, 38 lifitegrast, 40 linaclotide, 29 linezolid, 11 LINZESS, 29 liothyronine, 28 LIPOFEN, 15 liraglutide, 23, 25 liraglutide/insulin degludec, 23 lisdexamfetamine, 20 lisinopril, 13 lisinopril/hydrochlorothiazide, 13 lithium carbonate, 21 lithium carbonate ext-rel tabs 300 mg, 21 lithium carbonate ext-rel tabs 450 mg, 21 LITHOBID, 21 lixisenatide/insulin glargine, 23 LOESTRIN 1.5/30, 25 LOESTRIN 1/20, 25 LOESTRIN FE 1.5/30, 25 LOESTRIN FE 1/20, 25 LOKELMA, 28 LOMOTIL, 28 loperamide, 28 LOPID, 15 lopinavir/ritonavir soln, 10 lopinavir/ritonavir tabs, 10 LOPRESSOR, 15 LOPRESSOR HCT, 16 LOPROX, 37 lorazepam, 18 losartan, 14 losartan/hydrochlorothiazide, 14 LOSEASONIQUE, 26 LOTENSIN, 13 LOTENSIN HCT, 13 loteprednol, 40 LOTREL, 13 lovastatin, 15 LOVAZA, 15 lubiprostone, 29 LUCENTIS, 41 luliconazole, 37 LUMIGAN, 41 LUPRON DEPOT, 12 lurasidone, 20 lusutrombopag, 32 LYNPARZA, 12 LYSODREN, 13

M macitentan, 17 MACROBID, 11 MALARONE, 9 malathion, 39 MARINOL, 29 MATULANE, 13

Page 51: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

51

MAXALT, 21 MAXIDEX, 40 MAXITROL, 40 MAXZIDE, 17 MAYZENT, 22 mebendazole chewable, 11 meclizine, 29 MEDROL, 27 medroxyprogesterone acetate, 28 medroxyprogesterone acetate 150 mg/mL, 26 mefloquine, 9 MEGACE ES, 28 megestrol acetate susp, 28 megestrol acetate tabs, 12 meloxicam, 7 melphalan, 11 memantine, 19 memantine ext-rel, 18 memantine/donepezil, 18 mepolizumab, 36 mercaptopurine, 11 mesalamine delayed-rel caps, 29 mesalamine delayed-rel tabs, 29 mesalamine ext-rel caps, 29 mesalamine supp, 29 mesalamine susp, 29 metaxalone, 22 metformin, 23 metformin ext-rel, 23 methadone, 7 methazolamide, 16 methimazole, 28 methocarbamol, 22 methotrexate, 11, 33 methotrexate auto-injector, 33 methoxsalen oral, 37 methyldopa, 17 METHYLIN, 20 methylphenidate, 20 methylphenidate ext-rel, 20 methylprednisolone, 27 metoclopramide, 29 metolazone, 16 metoprolol succinate ext-rel, 15 metoprolol tartrate, 15 metoprolol/hydrochlorothiazide, 16 METROCREAM, 39 METROGEL, 39 METROGEL-VAGINAL, 31 METROLOTION, 39 metronidazole, 11, 31 metronidazole crm 0.75%, 39 metronidazole gel 0.75%, 39 metronidazole gel 1%, 39 metronidazole lotion 0.75%, 39 MICARDIS, 14 MICARDIS HCT, 14 midodrine, 17 midostaurin, 12 minocycline, 9 mirabegron ext-rel, 31 MIRAPEX, 20 MIRCETTE, 26 MIRENA, 26 mirtazapine, 19 misoprostol, 30

mitotane, 13 MOBIC, 7 mometasone crm, lotion, oint 0.1%, 38 mometasone spray, 36 montelukast, 35 morphine, 7 morphine ext-rel, 7, 8 morphine supp, 7 morphine/naltrexone ext-rel, 8 MOVANTIK, 30 MOXEZA, 39 moxifloxacin, 9, 39 MOZOBIL, 32 MS CONTIN, 8 MUGARD, 39 MULPLETA, 32 MULTAQ, 14 multivitamins/fluoride drops, tabs, 34 multivitamins/fluoride/iron drops, tabs, 34 mupirocin oint, 37 MUSE, 30 MYAMBUTOL, 10 mycophenolate mofetil, 33 mycophenolate sodium delayed-rel, 33 MYDAYIS, 20 MYLERAN, 11 MYRBETRIQ, 31 MYSOLINE, 18

N nabumetone, 7 nadolol, 15 naftifine, 37 NAFTIN, 37 naldemedine, 30 naloxegol, 30 naloxone inj, 22 naloxone nasal spray, 22 naltrexone, 22 NAMENDA, 19 NAMZARIC, 18 naproxen sodium tabs, 7 naproxen tabs, 7 naratriptan, 21 NARCAN, 22 NARDIL, 19 natalizumab, 22 nateglinide, 24 nebivolol, 15 neomycin/polymyxin B/bacitracin/hydrocortisone oint, 40 neomycin/polymyxin B/dexamethasone, 40 neomycin/polymyxin B/gramicidin, 39 neomycin/polymyxin B/hydrocortisone, 41 neomycin/polymyxin B/hydrocortisone susp, 40 nepafenac, 40 netarsudil, 41 netarsudil/latanoprost, 41 NEULASTA, 31 NEUPRO, 20 NEURONTIN, 18 NEVANAC, 40 nevirapine, 10 nevirapine ext-rel, 10 niacin ext-rel, 15 NIASPAN, 15 nifedipine ext-rel, 16

Page 52: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

52

nintedanib, 36 niraparib, 12 nitisinone, 27 NITRO-DUR, 17 nitrofurantoin ext-rel, 11 nitrofurantoin macrocrystals, 11 nitrofurantoin susp, 11 nitroglycerin lingual spray, 17 nitroglycerin sublingual, 17 nitroglycerin transdermal, 17 NITROLINGUAL, 17 NITROSTAT, 17 NIVESTYM, 31 NIZORAL, 37 NORCO, 8 norelgestromin/EE, 26 norethindrone, 26 norethindrone acetate, 28 norethindrone acetate/EE 1.5/30, 25 norethindrone acetate/EE 1.5/30 and iron, 25 norethindrone acetate/EE 1/20, 25 norethindrone acetate/EE 1/20 and iron, 25 norethindrone acetate/EE 1/20 and iron chewable, 25 norethindrone/EE, 26 norethindrone/EE 0.5/35, 26 norethindrone/EE 1/35, 26 norgestimate/EE, 26 norgestimate/EE 0.25/35, 26 norgestrel/EE 0.3/30 - Low-Ogestrel, 25 NORPACE, 14 NORPACE CR, 14 NORPRAMIN, 19 nortriptyline, 19 NORVIR, 10 NOVOEIGHT, 32 NOVOLIN 70/30, 24 NOVOLIN N, 24 NOVOLIN R, 24 NOVOLOG, 24 NOVOLOG MIX 70/30, 24 NUBEQA, 12 NUCALA, 36 NUCYNTA, 8 NUCYNTA ER, 8 NUEDEXTA, 22 NULYTELY, 30 NUVARING, 26 NUWIQ, 32 nystatin, 9, 37

O OCUFLOX, 39 ODEFSEY, 10 ODOMZO, 12 OFEV, 36 ofloxacin, 39 ofloxacin otic, 41 olanzapine, 20 olaparib, 12 olmesartan, 14 olmesartan/amlodipine/hydrochlorothiazide, 14 olmesartan/hydrochlorothiazide, 14 olodaterol, CFC-free aerosol, 35 olopatadine, 39 olopatadine spray, 36 omalizumab, 36

omega-3 acid ethyl esters, 15 omeprazole delayed-rel, 30 OMNIPOD INSULIN INFUSION PUMP, 24 ondansetron, 29 ONZETRA XSAIL, 21 OPSUMIT, 17 ORALAIR, 32 ORENITRAM, 17 ORFADIN, 27 ORILISSA, 26 orphenadrine/aspirin/caffeine, 22 ORTHO MICRONOR, 26 ORTHO-NOVUM 1/35, 26 ORTHO-NOVUM 7/7/7, 26 oseltamivir, 11 ospemifene, 28 OSPHENA, 28 OTEZLA, 32 OVIDE, 39 OVIDREL, 27 oxaprozin, 7 oxazepam, 18 oxcarbazepine, 18 oxcarbazepine ext-rel, 18 OXSORALEN-ULTRA, 37 OXTELLAR XR, 18 oxybutynin, 31 oxybutynin ext-rel, 31 oxycodone caps, tabs 5 mg, 7 oxycodone concentrate 20 mg/mL, 7 oxycodone ext-rel, 8 oxycodone tabs 15 mg, 30 mg, soln 5 mg/5 mL, 8 oxycodone/acetaminophen 5/325, 7 OZEMPIC, 23

P palbociclib, 12 PAMELOR, 19 pancrelipase, 30 pancrelipase delayed-rel, 30 pantoprazole delayed-rel, 30 paricalcitol, 28 PARLODEL, 20 PARNATE, 19 paroxetine HCl, 19 paroxetine HCl ext-rel, 19 paroxetine mesylate, 23 PATADAY, 39 PATANASE, 36 PATANOL, 39 patiromer sorbitex, 28 PAXIL, 19 PAXIL CR, 19 PAZEO, 39 pazopanib, 12 peg 3350/electrolytes, 30 PEGASYS, 33 pegfilgrastim, 31 pegfilgrastim-cbqv, 31 peginterferon alfa-2a, 33 peginterferon alfa-2b, 33 pegvisomant, 23 penicillin VK, 9 PENTASA, 29 PEPCID, 29 perampanel, 18

Page 53: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

53

PERFOROMIST, 35 perindopril, 13 permethrin 5%, 39 perphenazine, 20 phenelzine, 19 phenobarbital, 18 phenytoin, 18 phenytoin sodium extended, 18 PHOSLYRA, 28 PICATO, 37 pilocarpine tabs, 30 pimecrolimus, 38 pindolol, 15 pioglitazone, 24 pioglitazone/glimepiride, 24 pioglitazone/metformin, 24 pirfenidone, 36 PLAQUENIL, 33 plerixafor, 32 podofilox, 39 polymyxin B/bacitracin, 39 polymyxin B/trimethoprim, 39 POLYTRIM, 39 pomalidomide, 12 POMALYST, 12 potassium chloride ext-rel, 33 potassium chloride liquid, 33 potassium citrate ext-rel, 31 pramipexole, 20 pramipexole ext-rel, 19 pramlintide, 23 PRANDIN, 24 prasugrel, 32 PRAVACHOL, 15 pravastatin, 15 PRECOSE, 23 PRED MILD, 40 prednisolone, 27 prednisolone acetate, 40 prednisolone acetate 1%, 40 prednisolone phosphate 1%, 40 prednisone, 27 pregabalin, 21 PREMARIN, 26, 27 PREMPHASE, 27 PREMPRO, 27 prenatal vitamins, 33 prenatal vitamins/DHA/docusate/folic acid, 33 prenatal vitamins/docusate/folic acid, 33 prenatal vitamins/docusate/folic acid + DHA, 34 prenatal vitamins/folic acid + pyridoxine, 34 PREZCOBIX, 9 PREZISTA, 10 PRILOSEC, 30 primidone, 18 probenecid, 7 procarbazine, 13 PROCARDIA XL, 16 prochlorperazine, 29 PROCTOFOAM-HC, 30 progesterone gel, 28 progesterone vaginal inserts, 28 progesterone, micronized, 28 PROLASTIN-C, 36 PROLIA, 25 PROMACTA, 32

promethazine, 29 PROMETRIUM, 28 propafenone, 14 propafenone ext-rel, 14 propranolol, 15 propranolol ext-rel, 15 propylthiouracil, 28 PROSCAR, 30 PROVERA, 28 PULMICORT FLEXHALER, 36 PULMICORT RESPULES, 36 PULMOZYME, 35 PYLERA, 30 pyrazinamide, 10 pyridostigmine, 22 pyridostigmine ext-rel, 22

Q QUESTRAN/QUESTRAN LIGHT, 15 quetiapine, 20 quetiapine ext-rel, 20 quinapril, 13 quinapril/hydrochlorothiazide, 13 QVAR REDIHALER, 36

R ragweed pollen allergen extract, 32 RAGWITEK, 32 raloxifene, 28 raltegravir, 10 ramelteon, 21 ramipril, 13 ranibizumab, 41 ranitidine, 29 ranolazine ext-rel, 17 rasagiline, 19 RASUVO, 33 RAZADYNE, 19 RAZADYNE ER, 19 REBIF, 22 REBINYN, 32 REGLAN, 29 RELENZA, 11 RELPAX, 21 REMERON, 19 repaglinide, 24 REPATHA, 15 REQUIP XL, 20 RESTASIS, 40 RESTORIL, 21 RETACRIT, 31 RETIN-A, 37 RETROVIR, 10 REVATIO, 17 REVLIMID, 12 RHOPRESSA, 41 ribavirin, 11 ribociclib, 12 ribociclib + letrozole, 12 RIFADIN, 10 rifampin, 10 rifaximin 550 mg, 11 rilpivirine, 10 RINVOQ, 32 riociguat, 17 risankizumab-rzaa, 32 risedronate, 25

Page 54: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

54

risedronate delayed-rel, 25 RISPERDAL, 20 RISPERDAL CONSTA, 20 risperidone, 20 risperidone long-acting injection, 20 RITALIN, 20 ritonavir, 10 rivaroxaban, 31 rivastigmine, 18 rivastigmine transdermal, 19 rizatriptan, 21 ROBAXIN, 22 ROCALTROL, 28 ROCKLATAN, 41 roflumilast, 36 rolapitant, 29 ropinirole, 19 ropinirole ext-rel, 20 rosuvastatin, 15 rotigotine transdermal, 20 ROWASA, 29 ROXICODONE, 8 RUBRACA, 12 rucaparib, 12 RUCONEST, 33 RYDAPT, 12 RYTHMOL SR, 14

S sacubitril/valsartan, 17 SALAGEN, 30 salmeterol xinafoate, 35 SANCUSO, 29 sapropterin, 28 SAXENDA, 25 scopolamine transdermal, 29 SEASONIQUE, 26 secukinumab, 32 selegiline, 19 selenium sulfide lotion 2.5%, 37 selexipag, 17 semaglutide, 23 SENSIPAR, 25 SEREVENT, 35 SEROQUEL, 20 sertraline, 19 sevelamer carbonate, 28 sildenafil, 17, 31 SILENOR, 21 silodosin, 30 SILVADENE, 37 silver sulfadiazine, 37 SIMBRINZA, 40 simvastatin, 15 SINEMET, 20 SINEMET CR, 20 siponimod, 22 sirolimus, 33 sitagliptin phosphate, 23 sitagliptin/metformin, 23 sitagliptin/metformin ext-rel, 23 SKELAXIN, 22 SKYLA, 26 SKYRIZI, 32 sodium hyaluronate, 8 sodium sulfate/potassium sulfate/magnesium sulfate, 30

sodium zirconium cyclosilicate, 28 sofosbuvir/velpatasvir, 11 sofosbuvir/velpatasvir/voxilaprevir, 11 solifenacin, 31 SOLIQUA, 23 SOLIRIS, 32 solriamfetol, 22 somatropin, 27 SOMATULINE DEPOT, 23 SOMAVERT, 23 sonidegib, 12 SOOLANTRA, 39 SORIATANE, 37 sotalol, 14 soy phospholipid/glycerol dioleate, 39 SPIRIVA, 34 spironolactone, 13 spironolactone/hydrochlorothiazide, 17 SPRYCEL, 12 STALEVO, 20 stavudine, 10 STELARA SUBCUTANEOUS, 32 STIOLTO RESPIMAT, 34 STRATTERA, 20 STRIBILD, 10 STRIVERDI RESPIMAT, 35 STROMECTOL, 11 SUBSYS, 7 sucralfate, 30 sucroferric oxyhydroxide, 28 sulfacetamide lotion 10%, 37 sulfacetamide oint 10%, 39 sulfacetamide soln 10%, 39 sulfacetamide/prednisolone phosphate 10%/0.25%, 40 sulfamethoxazole/trimethoprim, 11 sulfamethoxazole/trimethoprim DS, 11 sulfasalazine, 29 sulfasalazine delayed-rel, 29 sulindac, 7 sumatriptan, 21 sumatriptan inj, 21 sumatriptan nasal powder, 21 sumatriptan nasal spray, 21 sumatriptan/naproxen sodium, 21 sunitinib, 12 SUNOSI, 22 SUPARTZ FX, 8 SUPRAX, 9 SUPREP, 30 SUTENT, 12 suvorexant, 21 SYLATRON, 33 SYMBICORT, 36 SYMFI, 9 SYMFI LO, 10 SYMLINPEN, 23 SYMPROIC, 30 SYNJARDY, 24 SYNJARDY XR, 24 SYNTHROID, 28

T TABLOID, 11 tacrolimus, 33, 38 tadalafil, 17, 31 tamoxifen, 12

Page 55: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

55

tamsulosin, 30 TAPAZOLE, 28 tapentadol, 8 tapentadol ext-rel, 8 TARGRETIN, 13 TARKA, 13 tazarotene, 37 TAZORAC, 37 TECFIDERA, 22 TEGRETOL, 18 TEKTURNA HCT, 16 telmisartan, 14 telmisartan/hydrochlorothiazide, 14 temazepam, 21 TEMIXYS, 10 TEMODAR, 11 TEMOVATE, 38 temozolomide, 11 tenofovir alafenamide, 11 tenofovir disoproxil fumarate, 10 terazosin, 14 terbinafine tabs, 9 terbutaline, 35 terconazole, 31 teriflunomide, 22 teriparatide, 25 TESSALON, 35 testosterone cypionate, 23 testosterone enanthate, 23 testosterone gel, 23 testosterone soln, 23 testosterone transdermal, 23 tetrabenazine, 22 tetracycline, 9 thalidomide, 12 THALOMID, 12 theophylline ext-rel tabs, 36 thioguanine, 11 thiothixene, 20 tiagabine, 18 TIAZAC, 16 ticagrelor, 32 TIGAN, 29 TIKOSYN, 14 timolol hemihydrate, 40 timolol maleate, 40 timolol maleate gel, 40 TIMOPTIC, 40 timothy grass pollen allergen extract, 32 tinidazole, 11 tiotropium, 34 tiotropium/olodaterol, 34 TIVICAY, 10 tizanidine tabs, 22 TOBRADEX, 40 TOBRADEX ST, 40 tobramycin, 39 tobramycin inhalation soln, 35 tobramycin/dexamethasone oint 0.3%/0.1%, 40 tobramycin/dexamethasone susp 0.3%/0.05%, 40 tobramycin/dexamethasone susp 0.3%/0.1%, 40 TOBREX, 39 tofacitinib, 32 tofacitinib ext-rel, 32 TOFRANIL, 19 TOLAK, 37

tolterodine, 31 tolterodine ext-rel, 31 TOPAMAX, 18 topiramate, 18 topiramate ext-rel, 18 topotecan caps, 12 torsemide, 16 TOVIAZ, 31 tramadol, 8 tramadol ext-rel, 7 trandolapril, 13 trandolapril/verapamil ext-rel, 13 tranylcypromine, 19 TRAVATAN Z, 41 travoprost, 41 trazodone, 19 TRELEGY ELLIPTA, 34 TREMFYA, 32 treprostinil ext-rel, 17 TRESIBA, 24 tretinoin, 37 tretinoin - Avita, 37 tretinoin caps, 12 tretinoin gel microsphere, 37 TREXALL, 11 TREXIMET, 21 triamcinolone acetonide crm 0.5%, 38 triamcinolone acetonide crm, lotion 0.025%, 38 triamcinolone acetonide crm, lotion, oint 0.1%, 38 triamcinolone paste, 39 triamterene, 16 triamterene/hydrochlorothiazide, 17 TRIBENZOR, 14 trifluoperazine, 20 trifluridine, 40 trihexyphenidyl, 20 TRILEPTAL, 18 TRILIPIX, 15 trimethobenzamide, 29 trimethoprim, 11 TRINTELLIX, 19 TRIUMEQ, 9 TROKENDI XR, 18 trospium, 31 trospium ext-rel, 31 TRULICITY, 23 TRUSOPT, 40 TRUVADA, 10 TYKERB, 12 TYMLOS, 25 TYSABRI, 22

U UDENYCA, 31 ULORIC, 7 ULTRAM, 8 ULTRAVATE, 38 umeclidinium bromide, 34 umeclidinium/vilanterol, 34 upadacitinib, 32 UPTRAVI, 17 URECHOLINE, 31 uridine triacetate, 12 UROCIT-K, 31 URSO, 29

Page 56: Prescribing Guide 500H - 2020 - Caremark · sitagliptin/metformin ext-rel Janumet XR A separate entry for Janumet XR confirms that the extended-release product is on the Prescribing

56

ursodiol, 29 ustekinumab, 32

V VAGIFEM, 27 valacyclovir, 11 valbenazine, 22 valganciclovir, 10 VALIUM, 18 valproic acid, 18 valsartan, 14 valsartan/hydrochlorothiazide, 14 VANCOCIN, 11 vancomycin caps, 11 varenicline, 23 VARUBI, 29 VASCEPA, 15 VASERETIC, 13 VASOTEC, 13 VELPHORO, 28 VELTASSA, 28 VEMLIDY, 11 venlafaxine, 19 venlafaxine ext-rel, 19 verapamil ext-rel, 16 VFEND, 9 V-GO INSULIN INFUSION PUMP, 24 VIBERZI, 29 VIBRAMYCIN, 9 VICTOZA, 23 VIDEX EC, 10 vigabatrin, 18 VIGAMOX, 39 VIIBRYD, 19 vilazodone, 19 VIMPAT, 18 VIOKACE, 30 VIREAD, 10 VISCO-3, 8 VISTOGARD, 12 vitamin ADC/fluoride drops, 34 vitamin ADC/fluoride/iron drops, 34 voriconazole, 9 vorinostat, 13 vortioxetine, 19 VOSEVI, 11 VOTRIENT, 12 VRAYLAR, 20 VYTORIN, 15 VYVANSE, 20

W warfarin, 31 WELLBUTRIN SR, 19 WELLBUTRIN XL, 19

X XALATAN, 41 XARELTO, 31 XELJANZ, 32 XELJANZ XR, 32 XELODA, 11 XIFAXAN, 11 XIGDUO XR, 24 XIIDRA, 40 XOLAIR, 36 XTAMPZA ER, 8 XTANDI, 12 XULTOPHY, 23

Y YASMIN, 25 YONSA, 12

Z zafirlukast, 35 ZANAFLEX, 22 zanamivir, 11 ZARONTIN, 18 ZEJULA, 12 ZEMBRACE SYMTOUCH, 21 ZEMPLAR, 28 ZENPEP, 30 ZESTORETIC, 13 ZESTRIL, 13 ZIAC, 16 ZIAGEN, 10 zidovudine, 10 zileuton ext-rel, 35 ziprasidone, 20 ZITHROMAX, 9 ZOCOR, 15 ZOFRAN, 29 ZOLINZA, 13 zolmitriptan, 21 zolmitriptan nasal spray, 21 ZOLOFT, 19 zolpidem, 21 zolpidem ext-rel, 21 zolpidem sublingual, 21 ZOMIG, 21 zonisamide, 18 ZOVIRAX, 11 ZUBSOLV, 22 ZYCLARA, 37 ZYLOPRIM, 7 ZYPREXA, 20